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INFLUENCE OF STRESSFUL LIFE EVENTS ON THE DEVELOPMENT OF TYPE 2
DIABETES
ABSTRACT
JOSHUA T. MINKS
UNIVERSITY OF MISSOURI – ST. LOUIS
DEPARTMENT OF NURSING
Spring 2019
This study examined the relationship between distress and the development of Type
2 diabetes mellitus (T2DM) in the presence of established risk factors. Distress secondary
to mental health disparities, stressful life events, and work conditions has been shown to
promote insulin resistance and the development of T2DM.
Subjects (N=79) diagnosed with T2DM within the previous six months were
recruited from SSM Health Centers and VA Medical Centers in the greater St. Louis area.
They completed the Recent Life Changes Questionnaire, ENRICHD Social Support
Instrument, and a demographic survey and analyses were conducted to determine
differences between the veteran and non-veteran subsamples, as well as determine the
influence of distress and social support in the presence the established risk factors of age,
BMI, and genetic risk for diabetes.
The average subject’s hemoglobin A1c (HbA1c) was 8.3%, BMI was 34.1, ESSI
score was 15, and RLCQ score was 297.6 LCU. Twenty-nine subjects were diagnosed
with a mental illness. Age and BMI had significant influence on the development of
T2DM for the sample (β=-.241, p=.031 and β=-.293, p=0.10, respectively) while distress
was not significant (β=-.040, p=.721). The mean HbA1c for the subgroups were
significantly different (t=2.768, p=.007) The differences in age, BMI (t=-1.158, p=.250),
GRD (t=-1.279, p=.206), and RLCQ scores (t=-.487, p=.628) were not significantly
different.
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CHAPTER I
INTRODUCTION
Type 2 diabetes mellitus remains a problematic disease of growing proportions due
to risk factors such as advancing age, genetic risk for DM, and obesity (Centers for
Disease Control and Prevention [CDC], 2011). According to the CDC (2011), T2DM
accounted for 90 to 95% of all diabetes cases. In 2012, 29.1 million people – 9.3% of the
U.S. population – had diabetes yet only 21 million were diagnosed (CDC, 2014). Half of
Americans may develop prediabetes or DM by 2020 (Berkrot, 2010). The CDC (2011)
projects that as many as one out of every three people or more in the U.S. may develop
DM by 2050. The projected United States population for 2050 is 438 million citizens
(Passel & Cohn, 2008). By 2050, 146 million people are expected to be diagnosed with
DM.
Total national health expenditure in 2012 was $2.8 trillion dollars (Martin et al.,
2014). Diabetes care cost Americans $245 billion in 2012. This cost increased
approximately $34.8 billion per year since 2007 (ADA, 2013). In 2050 at the current
trajectory of DM care costs, DM care alone will cost Americans over $1.5 trillion dollars.
The average annual cost for healthcare for individuals over 50 years old
recently diagnosed with DM was $4,174 greater than someone of the same age without
DM between the years 2000 and 2004; this cost increased by approximately $158 per
year (Trogdon & Hylands, 2008). Considering the veteran population, the percentage of
individuals with diabetes is estimated to be much greater, as approximately 25% of VA
patients have been diagnosed with diabetes (U.S. Department of Veteran Affairs, 2015).
With nearly 22 million veterans in 2014, the number of veterans with diabetes could be
approximately 5.5 million (U.S. Department of Veteran Affairs, 2016). Buddin and Han
6

(2012) found that DM ranked among the top 10 service-connected disabilities (SCDs) for
veterans who began receiving benefits in 2009 (n=23,508; 2.9%).
Established Influences
Although genetic predisposition influences the development of T2DM, other factors
such as advancing age, exercise, nutrition, and distress also influence the onset of T2DM
(American Diabetes Association [ADA], 2004; Guthrie & Guthrie, 2004; LaMonte, Blair,
& Church, 2004; Raison & Miller, 2003). The research suggests that genetic
predisposition alone may be insufficient to influence the development of T2DM and that
other risk factors may need to be present to produce sufficient insulin resistance for a
diagnosis of T2DM (Guthrie & Guthrie, 2004; Hamman, 1992).
Since T2DM can occur at nearly any age, the research suggests that lifestyle factors
may pose a greater role in the onset of diabetes (DM) than previously suspected (ADA,
2004; Patel & Macerollo, 2010). However, more than 20 years after Wales (1995) stated
that the physiological response to stressors is poorly understood, the influence of distress
on the development of T2DM remains controversial.
Research has demonstrated a connection between distress and insulin resistance
(Chandola et al., 2006; Eriksson, Hilding, Van den Donk, & Ostenson, 2013; EversonRose et al., 2004; Heraclides, Chandola, Witte, & Brunner, 2009; Mooy, De Vries,
Grootenhuis, Bouter, & Heine, 2000; Novak et al., 2013; Shiloah et al., 2013; Wu, Yang,
Thayer, & Andersen, 2014). According to Selye (1976), the state manifested during
distress is characterized by increased hypothalamic-pituitary-adrenal (HPA) axis activity
and adrenal hormone release. The serum level of cortisol – a glucocorticoid – increases,
promotes insulin resistance, and increases blood glucose levels (Chandola, Brunner, &
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Marmot, 2006; Innes, Vincent, & Taylor, 2007; McEwen, 2003a). The physiological
response to a stressor is in essence what it means to be stressed. As distress influences
insulin resistance and insulin resistance leads to the development of T2DM, research
indirectly suggests that distress influences the development of T2DM.
Problem Statement
Diabetes affects a large portion of society. Despite the extensive research describing
the significance of distress to the onset of T2DM, current research fails to adequately
describe the influence of distress and its relationship to established risk factors such as
aging, family history, and obesity (Chandola et al., 2006; Eriksson et al., 2013; EversonRose et al., 2004; Heraclides et al., 2009; Mooy et al., 2000; Novak et al., 2013; Shiloah
et al., 2003; Wu et al., 2014). A pilot study was conducted as a precursor to this study to
determine how to effectively approach research on the relationship between distress and
type 2 diabetes (T2DM) (Minks, 2013).
Examining the relationship among distress, social support, and the development of
T2DM, while acknowledging the concurrent risk presented by obesity as indicated by an
increased body mass index (BMI), advancing age, and genetic risk for diabetes, could
provide a better understanding about the etiology of this multifactorial disease.
Purpose of Study
The purpose of the study was to examine the influence of stressful life events, social
support, age, body mass index (BMI), and genetic risk for diabetes (GRD) prior to the
time of T2DM diagnosis. Stressful life events are limited to six months prior to the onset
of diabetes diagnosis in order to further explore the effect of distress. In addition, this
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study seeks to determine if there is a difference between veterans and non-veterans for
risk of developing T2DM.
Research Questions
The research questions guiding this study included:
1.

In adults with T2DM, how much distress was present six months prior to the
diagnosis of T2DM?

2.

What is the individual and combined effect of distress, social support, age, BMI,
and GRD on the HbA1c level?

3.

In adults with T2DM, what is the difference in risk factors between veteran and
non-veteran subjects?

Definition of Terms
Definitions reflect variables from the research questions. Theoretical definitions
were noted for distress, social support, blood glucose control, BMI, age, genetic risk for
diabetes. Operational definitions are also provided in the methods section in Table 1.
Distress.
Lazarus and Folkman (1984) theoretically defined distress as harm or loss, threat
from anticipated loss, or challenges that pose potential for gain or growth. The theoretical
definition of stress considers the impact of environmental demands on an individual’s
perception of stressors. Selye (1976) defined stress as the state manifested by a specific
syndrome that consisted of all the nonspecifically-induced changes within a biologic
system, comparable to McEwen’s (1998) theory of allostasis and allostatic load.
In addition to the distress produced from environmental demands, mental health
disorders such as depression can produce distress. Several empirical studies investigated
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the effect of distress on insulin resistance and T2DM in terms of depression (Eaton,
Armenian, Gallo, Pratt, & Ford, 1996; Everson-Rose et al., 2004; Khambaty, Callahan, &
Stewart, 2018; Palinkas, Lee, & Barrett-Connor, 2004; Vrany, Berntson, Khambaty, &
Stewart, 2016).
For the purpose of this study, distress caused by stressful life events was
operationally defined as a total score on the RLCQ (See Appendix A). The RLCQ is a
73-item survey that measures the degree of distress in terms of life change units (Miller
& Rahe, 1997).
Social Support.
Social support is conceptually defined as the availability of people, groups, or
organizations that an individual can refer to when in need (Vaglio et al., 2004). The
availability of such factors can influence how an individual responds to a stressor (Roy &
Andrews, 1999). Lack of social support can be identified as attachment insecurity and
individuals can have heightened reactivity to stressors and deficits in their regulation of
emotions (Diamond & Fagundes, 2010). The pro-inflammatory response and depression
that can result from low social support can influence known risk factors for T2DM,
including gene expression and obesity (Kiecolt-Glaser, Gouin, & Hantsoo, 2010).
For the purpose of this study, social support was operationally defined as a total
score on the ESSI (See Appendix B). The ESSI is a seven-question survey that assesses
social support (Vaglio et al., 2004).
Body mass index.
An individual’s body mass presents potential risk for the development of T2DM
(ADA, 2004). The conceptual definition of BMI is an individual’s weight in proportion to
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the individual’s height (Keys, Fidanza, Karvonen, Kimura, & Taylor, 2014). For the
purpose of this study, BMI was operationally defined by calculating the BMI. The
formula for BMI calculation is: weight in kilograms (kg) divided by height as meters (m)
squared or kg/m2 (Keys et al., 2014).
Age.
Age is considered a risk factor for T2DM (ADA, 2004). However, Hamman (1992)
argued that the risk associated with age is actually a result of weight gain secondary to
sedentary activity that occurs with aging. Another commonly used name for T2DM,
adult-onset diabetes, acknowledges the relationship between age and T2DM (ADA,
2004). The conceptual definition of age is the incremental change in time as it relates to
an individual’s lifespan. For the purpose of this study, the operational definition of age
was the subject’s chronological age in years at the time of diagnosis as noted on the
demographic survey (See Appendix C).
Genetic risk for diabetes.
Researchers have identified T2DM as a genetic disease (ADA, 2004; Patel &
Macerollo, 2010; Guthrie & Guthrie, 2004; Hamman, 1992). For the purpose of this
study, GRD is conceptually defined as a family history of diabetes posing genetic risk for
the development of the disease (ADA, 2004). Genetic risk for diabetes was operationally
defined as the subject answering yes in response to the demographic survey question:
“Do you have a parent, grandparent, or sibling with diabetes?” (See Appendix C).
Blood Glucose Control.
Blood glucose control is determined by an individual’s blood glucose levels.
Individuals may be diagnosed with prediabetes or a category of increased risk, such as
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the presence of a fasting glucose 100 to 125mg/dL or an HbA1c between 5.7% and 6.4%
(Patel & Macerollo, 2010). Blood glucose control is conceptually defined as the degree of
variance between glucose levels and insulin concentrations with higher variance meaning
less control. For the purpose of this study, blood glucose control was operationally
defined by results of an HbA1c laboratory test.
Development of Type 2 Diabetes.
The variance between glucose levels and insulin concentrations may take time to
develop until a sufficient number of risk factors are present (Hamman, 1992). For the
purpose of this study, the term development refers to the period of time immediately
preceding the diagnosis of T2DM where a hioiioosufficient number of risk factors are
present.
Diagnosis of Type 2 Diabetes.
Type 2 diabetes mellitus is diagnosed by an HbA1C greater than or equal to 6.5%
(Patel & Macerollo, 2010; NIH, 2008; World Health Organization [WHO], 2011). For the
purpose of this study, the term diagnosis refers to the point in time when a provider
identifies a patient as having T2DM.
Justification for the Study
The number of people with diabetes is only expected to increase. The impact
diabetes has on the general population present a clear indication for continued research
efforts to determine the influence of risk factors to developing T2DM for effective
prevention, treatment, and, particularly, cost control.
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Assumptions
The theories proposed by Selye (1976), Lazarus and Folkman (1984), and McEwen
(1998) provided assumptions relevant to the study. The assumptions are divided into
respective sections, starting with Selye’s (1976) GAS. Assumptions from the GAS
included:
1.

Stress is a specific state resulting from a syndrome.

2.

The amount of adaptability an individual possesses is finite.

3.

Diabetes (DM) is not always due to an insufficiency of insulin formation (p. 266).

4.

Overwhelming stress can breakdown the body’s protective mechanisms.

5.

Poor adaptation influences the development of disease.

6.

Each individual responds uniquely to stress due to inherited health-related factors
and characteristics acquired from interaction with the environment.
Assumptions pertaining to Lazarus and Folkman’s (1984) stress, appraisal, and

coping theory included:
1.

An individual’s experiences with various stressors influence that individual’s
perception of new stressors.

2.

Familiar types of stressors pose little to no distress to an individual while unfamiliar
stressors can pose much greater distress.

3.

An individual’s perception of a stressor influences that individual’s options for
adapting to the stressor.

4.

Stakes such as commitments to others and spiritual beliefs influence an individual’s
perception of a stressor.
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5.

Distress can increase if an individual is unable to control the development of an
outcome.

6.

Distress can increase if an individual is uncertain of the consequences posed by a
stressor.

7.

Factors such as the time available to appraise stressors and repetition of stressors
can influence distress.

8.

The ability to cope with stressors is constantly changing and uses a combination of
unconscious and conscious processes in response to the perception of a stressor.
Assumptions pertaining to McEwen’s (1998) theory of allostasis and allostatic load
included:

1.

Complex neuroendocrine processes stimulate a combination of biological changes
in response to a stressor.

2.

Multiple stressors require greater demands on the neuroendocrine system to
stimulate specific biological changes in response to the respective stressors.

3.

The overactive response of the neuroendocrine system can increase the risk for the
development of diseases such as T2DM.
Assumptions related to the data collection process and the design of the study were:

1.

Subjects are honest.

2.

Subjects are able to recall events from the previous six months.

3.

Subjects can complete the surveys at the clinic where they receive care during a
face-to-face interview or by telephone.

4.

Subjects speak English.

5.

Subjects understand that the term diabetes is not diabetes insipidus.
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6.

Hemoglobin A1c is a reasonable way to measure an individual’s level of insulin
resistance secondary to chronic stress.

Delimitations
The study was limited to adults 18 years or older, excluding pregnant women,
residents of prisons or mental institutions, and the mentally handicapped. The adults were
diagnosed with T2DM within the previous six months and received diabetes care services
from hospitals or clinics within the greater area of St. Louis County, including SSM
Health and Veterans Affairs (VA) facilities.
Kang, Rice, Park, Turner-Henson, and Downs (2010) warn that the framework
doesn’t recognize the influence of multiple coexisting acute stressors. Retrospective
analysis of acute stressors poses unique challenges as a subject’s accuracy in recalling
daily stress loads occurring prior to the diagnosis of T2DM, and the investigator’s
interpretation of such data, could compromise the results.
The investigator recognizes that the recall timeframe for subjects diagnosed with
T2DM up to six months prior to the day of the interview is much longer than subjects
diagnosed with T2DM less than a week prior to the day of the interview. Subjects
recalling events and support six months prior to a diagnosis of T2DM given six months
ago have a greater recall timeframe that could impact their results on the RLCQ and
ESSI.
Although social support was evaluated, discussing the coping methods of the
subjects was beyond the scope of the study. Because the literature indicated a great
degree of complexity regarding appraisal and neuroendocrine response mechanisms, the
investigator did not attempt to determine specifics regarding the nature of physiological
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mechanisms promoting the development of T2DM (Lazarus & Folkman, 1984; McEwen,
1998; Selye, 1976).
Summary
Despite the known influence of genetic predisposition and environmental factors,
T2DM remains a complex disease of multifactorial origin (Hamman, 1992). Individuals
with known (or established) risk factors may not develop T2DM. The lack of disease in
individuals with established risk factors suggests that other contributing factors must
exist.
Many stressors encountered on a daily basis influence the stress response through
the activation of the HPA axis (Selye, 1976). Chronic activation of the HPA axis –
resulting in constant elevated levels of cortisol – promotes the risk for T2DM (Innes et
al., 2007; Kendall-Tackett, 2009; McEwen, 1998). The association between distress and
the HPA axis promoting insulin resistance suggests that T2DM may result from
ineffective coping in response to distress in the presence of established risk factors.
The problem in determining if distress influences the onset of T2DM is that
individuals respond to stressors differently (Shiloah et al., 2003; Wales, 1995). Not to
mention, each time a specific stressor occurs, the individual may respond differently in
terms of the secondary appraisal as a result of past experience with the stressor (Lazarus
& Folkman, 1984). Understanding the influence of distress on the development of T2DM
remains a pertinent challenge for further examination.
Several assumptions and limitations regarding the theories developed by Selye
(1976), Lazarus and Folkman (1984), and McEwen (1998) and the data collection process
formed the foundation for the study. Three research questions were posed.

16

With the projected healthcare cost of diabetes management alone in 2050 being
over $1.5 trillion, further research is needed to better understand the etiology of T2DM.
Understanding the relationship of distress and coping with established risk factors such as
obesity and familial history of diabetes could improve prevention and treatment
measures, as well as reduce the projected expenditure for diabetes management.
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CHAPTER II
REVIEW OF THE LITERATURE
The influence of distress on insulin resistance and type 2 diabetes (T2DM), as well
as concepts about stress and coping, are reviewed in the literature. Literature regarding
glucocorticoids (GCs), insulin resistance, metabolic syndrome, and specific forms of
distress such as depression, strain from work demands, and traumatic life events support
the plausibility of distress as a risk factor for T2DM. The literature review included
theoretical and empirical literature.
Pathophysiology of Stress
Selye (1976) stated that glucocorticoids (GCs) help cells adapt to stressors by
preventing excessive cellular activity, which decreases energy demands. The sympathetic
nervous system (SNS) and cellular stimulation trigger the stress response. Innes et al.
(2007) identified the SNS as the central stimulus of the stress response secondary to the
central secretion of catecholamines such as norepinephrine and epinephrine. The SNS
responds to an individual’s perception – negative appraisal – of a stressor that triggers the
stress response. Selye (1976) stated that cells outside the central nervous system (CNS)
could also stimulate a stress response. He identified the stimulant as an alarm signal;
injured or strained cells stimulate a stress response to support effective adaptation to
inflammation.
Straub, Dhabhar, Bijlsma, and Cutolo (2005) studied the use of dexamethasone to
describe the balance between pro-inflammatory and anti-inflammatory factors. Where
their research focused on levels of GCs in relation to the immune response, it also
indicates that a stress response resulting in elevated levels of GCs influences blood
glucose levels.
18

Selye (1976) argued that distress is the common denominator for all adaptive
reactions in the body. When the conceptual model with the physiological components
that generate the stress response – limbic system, hypothalamus, pituitary, and adrenal
glands – is considered, Selye’s comment becomes clearer.
The hippocampus and amygdala, parts of the limbic system, influence emotional
responses to distressing stimuli (Dedovic, Aguiar, & Pruessner, 2009). The limbic system
contains memories and life experiences that trigger neuroendocrine response from the
hypothalamus down the cascade known as the hypothalamic-pituitary-adrenal (HPA) axis
(Fava, 1994; Innes et al., 2007). Ultimately the HPA axis results in the release of cortisol
(Innes et al., 2007; Selye, 1976). McEwen (1998) identified this neuroendocrine process
as allostasis. Distress stemming from negative perceptions, lifestyle choices, and general
health can have considerable influence on cortisol secretion and glucose management.
Delaunay et al. (1997) demonstrated that GCs directly influence insulin production
from β cells in the pancreas of transgenic rats. Their research suggests that GCs produced
by the stress response can influence blood glucose levels. Allostasis becomes quite
complex as GCs influence insulin resistance and insulin production. The progressive
research on the relationship between steroids and insulin resistance may promote greater
understanding.
Early studies examined exogenous glucocorticoid-induced insulin resistance (Owen
& Cahill, 1973; Pagano et al., 1983). In 1951, Kinsell et al. identified a potential
relationship between GCs and insulin resistance, noting the suppression of fastinginduced hyperketonemia and ketonuria secondary to exogenous steroids in subjects
without endocrinopathies (as cited in Owen & Cahill, 1973). Owen and Cahill (1973)
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demonstrated that twice daily injections of cortisone (an exogenous glucocorticoid)
increased blood glucose levels within six days while subjects fasted. The data suggest
that increased levels of GCs can increase blood glucose levels.
Recognizing the influence of exogenous steroids such as cortisone, endogenous
GCs must follow suit and influence blood glucose levels similarly. Distressing non-work
and work-related factors influence the stress response and the resulting impact on insulin
resistance, a defining characteristic of T2DM.
Psychological Stress and Diabetes
Mooy et al. (2000) determined that an increasing number of non-work related
stressful life events remained significantly correlated with a diagnosis of T2DM after
adjusting for a family history of DM, physical activity, heavy alcohol consumption, and a
low level of education (OR=1.7 [1.0-2.7], p<0.05). After adjusting for age and sex, the
odds incrementally increased by roughly 20% for each additional non-work event such as
death of a child, friend, partner, or relative (OR=1.2, CI=1.1-2.5, p<0.05). Acute
psychotic distress has also been associated with hyperglycemia and hyperinsulinemia
(Shiloah et al., 2003).
During an eight year study, depression was associated with higher non-fasting
plasma glucose levels (p=0.001) and risk for T2DM (OR=2.5, 95% CI [1.29-4.87]) while
controlling for BMI, sex, and age (Palinkas et al., 2004). Everson-Rose et al. (2004)
found that insulin resistance increased annually for depressed women and that African
American women had greater risk for T2DM secondary to depression after controlling for
established risk factors (OR=2.56, p=0.008). During a nine-year study on the effect of
collaborative depression treatment and risk for diabetes, a third of the sample (n=39)
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developed diabetes (Khambaty et al., 2018). Work stress in the form of high demands and
low control increased the risk for T2DM nearly twofold in civil service workers after
controlling for age, employment grade, health behaviors, BMI, blood pressure, and
cholesterol and C-reactive protein levels (OR=1.98, 95% CI [1.14-3.44]; Heraclides et al.,
2009).
The impact on veterans may be much greater as they experience not only strain
associated with family and work demands, but the potential strain associated with
traumatic events that potentially conflict with their individual personalities. The veteran
demographic at greatest risk for diabetes are older men with psychiatric disorders such as
post-traumatic stress disorder (PTSD) from combat or other trauma (Haas & Watts,
2005). As distress promotes insulin resistance and remains a risk factor for metabolic
syndrome, insulin resistance poses a risk for T2DM (Chandola et al., 2006; Vrijkotte,
Van Doornen, & De Geus, 1999).
Although primary appraisal of stressful stimuli can trigger a stress response, the
response depends on the secondary appraisal in terms of resources and individuals
perception of their ability to adapt, as indicated by Lazarus and Folkman (1984);
consequently, the degree of influence from the stressful stimuli is difficult to measure and
unique to the individual experiencing the stressor. Variables other than an individuals’
adaptability to stressful stimuli include selecting control groups for comparison and not
being able to apply results across sociocultural barriers (Wales, 1995). Despite these valid
concerns as they relate to measuring the influence of a single stressor, generalizations
regarding the cumulative impact of distressing factors according to McEwen (2003a) can
be more meaningful than identifying a specific stressor. Identifying that an individual is
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experiencing significant distress is more meaningful in terms of health consequences than
determining the impact of a specific stressor.
An individual’s perception of available measures for adaptation evolve from
individual experiences with stressors. Huxley stated that “Experience is not what happens
to a man; it is what a man does with what happens to him” (1933, p. 5). Although likely
intended to be more poetic, Huxley acknowledged the significance of an individual’s
perception of an event. Exposure to comparable events influence the perception of life
experiences can intensify or suppress the outcome of a stress response. The inherent
strain from the stress response can be cumulative in effect (Selye, 1976). Recognizing the
meaning of Selye’s (1976) remark, responding to various concurrent stressors can have
harmful physiological consequences if an individual is unable to successfully adapt to
distress. McEwen (1998) expands on this concept with his theory on allostasis and
allostatic load. The unresolved stressors remain as in stasis with their independent
physical demands. As new stressors arise, the physical demand for coping increases and
puts greater strain on the body.
Miller and Rahe (1997) identified the influence of positive and negative experiences
using the Recent Life Changes Questionnaire (RLCQ). Life events such as adopting a
child or losing a child can cause distress. Regardless of whether the individual has
something to gain such as more income or lose such as a loved one, the individual’s
appraisal of the situation will influence the stress response. To understand the potential
impact of distress on the development of T2DM, Mooy et al. (2000) determined that the
death of partner or moving from a house significantly correlated with the development of
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T2DM in subjects after adjusting for age and sex (OR=1.9, p<0.05 and OR=1.6, p<0.05,
respectively).
“Although the predisposition to DM is inherited, the onset depends on how the
body responds to distress as a latent diabetic tendency develops into the disease” (Selye,
1976, p.266). Determining the influence of perceived stress on the development of T2DM
establishes a more definitive understanding of the extent of environmental influence. As
distress may potentiate the impact of known risk factors for T2DM, identifying the
potential influence that distress has on the development of T2DM could help healthcare
providers in the prevention and treatment of T2DM. Memories and life experiences
influence an individual’s ability to adapt to adversity. In turn, memories and life
experiences influence neuroendocrine regulation.
Conceptual Framework
The investigator-designed conceptual model comprises the risk factors that pose
risk for the development of T2DM (See Figure 6). A compilation of Selye’s (1976)
General Adaptation Syndrome (GAS) and Roy’s Adaptation Model (RAM) as described
by Roy and Andrews (1999) were used for the conceptual framework of the pilot study
preceding this study. Considering the variances among subjects with similar stressful life
events, the relationship between stressors and individual responses to those stressors
appears more complex than previously considered. Where the biological mechanisms of
the stress response according to Selye are still applicable, adaptation according to Roy is
limited in explaining how an individual’s past experiences influence the perception of
stressors, as well as the cumulative effect of stressors on the stress response.
Further analysis of the literature related to stress and coping in nursing research
presented non-nursing theories that are more suitable for research on the stress response.
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Kang, Rice, Park, Turner-Henson, and Downs (2010) indicate that the complexity of the
stress response can be effectively described with a conceptual framework comprised of
Selye’s (1974) GAS, Lazarus and Folkman’s (1984) Transactional Model of Stress
(TMS), and McEwen’s (1998) Allostasis Theory.
The GAS emphasizes an individual’s biological response to strain while
acknowledging an individual’s unique perception of that strain (Selye, 1976). According
to Selye (1976), the state manifested during stress is characterized by increased HPA axis
activity and adrenal hormone release. The serum level of cortisol, a glucocorticoid,
increases, promotes insulin resistance, and increases blood glucose levels (Chandola et
al., 2006; Innes et al., 2007; McEwen, 2003a).
Perception is influenced by an individual’s appraisal of the strain. According to
Lazarus and Folkman (1984), primary appraisals determine whether that strain is benign,
either warranting no need to worry or potentially enhancing an individual’s well-being, or
poses risk for harm, loss, threat, or challenge. When significant life events occur, they
can present (a) considerable damage to an individual’s physical and or emotional wellbeing; (b) anticipatory losses as a result of consequences for intended or unintended
actions; (c) a sense of danger when values and goals appear to be in jeopardy, and or (d)
potential for personal or professional gain at the risk of greater demands on outcomes.
Appraisal is two-fold. First, an individual must determine if the stressor is
considered to be a threat or challenge; second, the individual must evaluate all the
possible methods for adaptation. The individual must determine if each method can be
successfully applied to meet the perceived needs of the stressor (Lazarus & Folkman,
1984). Relatively mild stressors experienced by a large number of individuals can be
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exponentially greater in terms of strain for individuals that perceive high stakes at risk
with the same stressor. “Even if they have considerable power to control the outcome,
any doubt [in an individual’s ability to successfully adapt to a stressor] can produce
considerable stress” (Lazarus & Folkman, 1984, p. 35).
As several factors in the appraisal process influence the physiological process of a
stress response, opposing endocrine hormones such as aldosterone and cortisol influence
the intensity of the stress response (Selye, 1976). Selye (1976) identified cortisol
secretion as the adaptive mechanism for effective coping. The GAS being the biological
response to a stressor (See Figure 1).

Figure 1. Compilation of the Stress Response and Corticosteroid Activity

Figure 1. During the Alarm Phase and Exhaustion Phase, the corticosteroid activity
increases as the resistance to stress decreases (Selye, 1976, p. 111 & p. 163). Printed with
permission for educational purposes.

The alarm stage begins with a trigger that stimulates cells to send a signal to the
hypothalamus. Considering the process of stress and coping according to Lazarus and
Folkman (1984), the alarm stage is comparable to the primary appraisal phase, deeming a
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stressor as a threat or a challenge. When a stressor is determined to be a threat or
challenge, the hypothalamus secretes corticotropin-releasing hormone (CRH) to activate
the stress response via the HPA axis (Selye, 1976).
The stage of resistance is fundamental to adaptation in the GAS. The stage of
resistance occurs when a suitable concentration of cortisol suppresses an over-reactive
response to the stressor (Selye, 1976). Despite the cognitive-degree of reasoning that
occurs to evaluate a stressor of physical or psychological origin, the physiological
response to the stressor remains the same. Regardless of the necessity for such a
response, the HPA axis leads to the production of cortisol, which enhances cardiovascular
function, helps regulate fluid volume levels, and promote mobilization of glucose stores
(McEwen, 2003b). The process of appraisal coupled with the GAS presents the
interaction between psychological and physiological mechanisms that contribute toward
adaptation. The stage of resistance may occur during the process of the secondary
appraisal until the initiation of the chosen method of adaptation.
The stage of exhaustion indicates that resistance or adaptation is no longer possible
as cellular death occurs (Selye, 1976). In the case of chronic stress, cells exposed to
cortisol for an excessive period of time prematurely die as a result of cellular apoptosis
(Sapolsky, 2004). The stage of exhaustion may occur if the chosen method of adaptation
does not result in resolution of the stressor.
In addition to the three stages of the GAS, Selye (1976) described three components
of disease manifestation: the stressor, the forces of resistance, and the forces of
submission. Disease manifestation is dependent upon the intensity, sequence of action,
systemic influence, and the relative proportions of these components. Regarding
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intensity, Selye (1976) stated that the ability to cope with the stressor is more significant
than the intensity of the stressor.
In regards to coping and the forces of resistance and submission, Lazarus and
Folkman’s (1984) description of an individual’s commitments and beliefs could be
representative of Selye’s concepts of resistance and submission. If a stressor threatens a
commitment such as a relationship with a partner or friend, a stressor poses greater strain.
As Lazarus and Folkman (1984) put it, an individual is more vulnerable to psychological
stress from the deeper the commitment and the greater the potential for threat or harm (p.
58). The degree of commitment related to the stressor could be a force of resistance that
motivates an individual to devote greater effort to pursuing a successful method of
adaptation. On the other hand, a deep commitment could present greater risk for
hopelessness and despair if an individual believes that no method of adaptation would be
sufficient.
Beliefs can regard premises of faith, hope, and a loci of control. Primary and
secondary appraisals can be influenced considerably by an individual’s beliefs (Lazarus
& Folkman, 1984). For example, when an individual possesses a high degree of
experience or knowledge about a phenomenon of interest, the individual is more cautious
of another’s beliefs that present conflicting experience or knowledge. The stressor poses
little strain and the primary appraisal of the stressor is likely to be benign rather than
threatening. However, if belief is lost, hope can change to hopelessness and present
considerable strain from a threatening stressor (Lazarus & Folkman, 1984).
Regarding the loci of control, the secondary appraisal of a stressor is influenced by
whether the individual believes he or she has control over events – internal locus of
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control – or believes control is left to God or fate – external locus of control. An internal
locus of control can present greater strain from an undesirable outcome and guilt that may
result from an individual’s belief that he or she should have been able to control the
outcome (Lazarus & Folkman, 1984; Roddenberry & Renk, 2010; Sapolsky, 2004;
Shupe, 1985). Although undesirable outcome can present greater strain for individuals
with an internal locus of control, those individuals are less likely to cope by avoiding
stressors than individuals with an external locus of control (Chung, Preveza, Papandreou,
& Prevezas, 2006).
The forces of resistance or submission could represent the individual’s perception
of the stressor depending on whether the individual previously experienced or understood
the significance of the stressor. The individual’s past experience with similar stressors, if
any, would in turn influence the individual’s perception of the current stressor. According
to Selye (1976), an individual’s ability to cope with stressors is influenced by the events
experienced in the individual’s life. The experienced events influence the individual’s
perception of the stressor and physiological response to the stressor.
As noted in Figure 2, the stress response is mediated through two pathways, the
endocrine system and the nervous system (Selye, 1976). The endocrine system acts
through the HPA axis to produce cortisol. The nervous system bypasses the HPA axis
and glandular activity during the stress response. Adrenaline and acetylcholine produced
by nerve endings act antagonistically in response to stress. For example, adrenaline
stimulates a hypertensive response to a psychological stressor producing feelings of
agitation while acetylcholine suppresses the hypertensive response (Selye, 1976).
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The stressor may have a specific or non-specific influence (Selye, 1976). A specific
stressor could be a localized injury such as an ankle sprain while the non-specific stressor
could be a systemic infection. Apart from the unique consequences posed by either
stressor, the resulting stress response depends upon the number of cells affected by the
stressor and the individual’s perception of the stressor (Selye, 1976).
Unique contextual factors can also influence primary and secondary appraisals.
Primary appraisals can be influenced by an individual’s experience with the stressor or a
comparable stressor; predictability of a stressor, warning signs prior to a reoccurring
stressful event produce less strain; event uncertainty, different from predictability, can
produce strain as individual’s anticipate a stressor that may not occur; and temporal
factors such as imminence and duration of a stressful event influence the complexity and
intensity of an appraisal process as an individual may have too much or too little time to
consider the impact of a stressor with acute or chronic intermittent consequences
(Lazarus & Folkman, 1984). Pending the imminence of a stressor, secondary appraisals
consider the efficacy of each method of adaptation may be evaluated for difficulty in
implementation of a method, extent to which a method can produce specific outcomes or
present other consequences, and the likelihood of a method to resolve the stressor
(Lazarus & Folkman, 1984). Considering the various types of stressful life events and
day-to-day stressors in relation to an individual’s ability to appraise the stressors and each
possible method for adaptation, the process of coping presents considerable complexity.
Although the appraisal process – primary and secondary appraisal – suggests a
simple algorithm for determining a method for adaptation, the process is far more
complex. Each method for adaptation can consist of multiple factors that are relevant to
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the stressor. Factors can include how an individual’s desired outcome interacts with the
immediate environment, as well as subconscious agendas. An individual may be unaware
of subconscious agendas that influence the individual’s appraisal of the stressor (Lazarus
& Folkman, 1984). The immediate environment with factors such as support systems like
church or interest groups, familial behaviors that influence an individual’s lifestyle
choices, and social interactions with family, friends, or partners that result in unique
experiences can guide the stress response toward an adaptive or maladaptive response.
Stressors resulting from significant personal events may produce a prolonged rise in
serum cortisol dependent on an individual’s ability to adapt to each of the events (Mooy
et al., 2000). Limited social support and ineffective coping may allow distress to endure.
Prolonged distress can permit persistent elevated serum cortisol levels. If serum cortisol
levels remain elevated, insulin resistance and T2DM can result (Cheung & Li, 2012;
Everson-Rose et al., 2004; Hankonen, Absetz, Haukkala, & Uutela, 2009; Heraclides et
al., 2009; Mooy et al., 2000; Novak et al., 2013; Uchida et al., 2012; Vrijkotte et al.,
1999).
Several of the studies suggest that the frequency of stressors can be as concerning
as the intensity of stressors. Lazarus and Folkman (1984) identify the variance as acute,
time-limited stressors and chronic intermittent or continuous stressors. The occurrence of
one or more acute, time-limited stressors coupled with chronic intermittent or continuous
stressors is tantamount to what an individual may experience in life. As Kang et al.
(2010) indicated, Dr. Bruce McEwen provides an exceptional description of the
cumulative effects of stress and stress adaptation in the stress, allostasis, and allostatic
load model.
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When stressors occur, whether benign or threatening, allostatic responses initiate
adaptive processes to cope with stressors via physiological mediators such as
glucocorticoids. According to Sterling and Eyer (1988), allostasis is essentially
“maintaining stability through [physiological] change” (as cited in McEwen, 2003b, p.
10). The process of allostasis is synonymous with the mediator pathways described by
Selye (1976), adaptation triggered by the hypothalamus as part of the HPA axis.
Allostatic responses trigger physiological changes to stressors and as with other
mechanisms in the body that respond to demand, greater or sustained change is needed
with greater demands. Allostatic load is the cost of adaptation and can lead to
pathophysiological consequences if mediators such as glucocorticoids are not efficiently
terminated (McEwen, 2003b; McEwen, 1998). Selye (1976) identified the correlation
between overwhelming stress, such as the stress posed by worrying, and
pathophysiological consequences. In some cases overwhelming stress can even lead to
death (Sapolsky, 2004).
McEwen (1998) describes four paradigms associated with allostatic load: frequent
stress, repeated stressors of the same type with inefficient adaptation, stressors that cease
while allostatic responses persist, and stressors that trigger primary allostatic responses
requiring assistance from secondary adaptive mechanisms (see Figure 3). In any of these
paradigms, the cost of adaptation includes elevated hormone levels such as epinephrine
and cortisol, which are intended to mobilize glucose for a fight-or-flight response to the
stressor (McEwen, 2003b; McEwen, 1998; Sapolsky, 2004). Whether the stressor is
physical in nature such as aerobic activity or psychological in nature such as the loss of a
loved one, an individual mounts the same biological response with varying degrees of
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intensity. The intensity of the biological response is influenced by an individual’s
appraisal of the stressor (Lazarus & Folkman, 1984). When the total cost of adaptation
from stressors over time exceed physical tolerance, pathophysiological consequences
such as hypertension and atherosclerosis can occur (McEwen, 2003b).

Figure 3. Four Paradigms of Allostatic
Load

Figure 3. Frequent stress represented by repeated hits; repeated stressors of the same
type with inefficient adaptation represented by lack of adaptation; stressors that cease
while allostatic responses persist represented by prolonged response; and stressors that
trigger primary allostatic responses requiring assistance from secondary adaptive
mechanisms represented by inadequate response. Reproduced with permission from
New England Journal of Medicine, Copyright Massachusetts Medical Society.
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Combining Selye’s (1976) GAS, Lazarus and Folkman’s (1984) TMS, and
McEwen’s (1998) Allostasis Theory creates a conceptual model that identifies essential
principles of the stress response. Selye’s (1976) GAS represents the physiological
response to stressors. Lazarus and Folkman’s (1984) cognitive appraisal model identifies
uniquely human psychological processes in interpreting stressors, the degree of strain if
any presented by the stressors, and the possible adaptation measures that could be used to
respond to the stressors. McEwen’s (1998) theory of allostasis and allostatic load presents
a key component as it represents the phenomenon of chronic stress.
Physiologic changes in the short-term during acute stress are meant to be adaptive.
When acute stressors such as running from an attacker, escaping a burning building, or
competing in a triathlon occur, elevated levels of hormones such as cortisol and
epinephrine promote adaptation. However, these physiologic changes are not meant to be
prolonged.
Unfortunately, the human body’s response to chronic stress is the same as the
response to acute stress. The human body is not designed to run a triathlon for several
weeks, let alone months to years. Persistent, unrelenting strain from any combination of
stressors ranging from life changing events such as retirement or a new addition to a
family dynamic to being a low-income, single parent raising children with special needs
can provoke prolonged physiologic changes that are harmful. As Selye (1976)
emphasized, “no disease solely results from maladaptation; however, the onset of many
diseases is facilitated by derangements of adaptive mechanisms” (p. 298). Elevated
glucose levels posing risk for the development of T2DM is no exception. Regardless of
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genetic risk for diabetes, maladaptive responses to stress pose considerable influence on
the development of T2DM (Selye, 1976).
Theoretical Literature
Roy, a nurse theorist, stated that the integrity of endocrine function has significant
influence on the human body (Roy & Andrews, 1999). She associated endocrine diseases
with glandular dysfunction or failure of target cells to respond to specific hormone(s).
Roy considered T2DM to be due to unresponsive target cells to insulin (Roy & Andrews,
1999). Endocrine diseases strictly resulted from cellular damage or genetic
predisposition. Elevated GCs only indicated pronounced regulator activity, a sign of
adaptation difficulty or ineffective coping (Roy & Andrews, 1999).
The literature regarding Roy’s Adaptation Model (RAM) and T2DM is limited to
coping with T2DM rather than the prevention of T2DM or other diseases (Roy &
Andrews, 1999). However, RAM indirectly suggests that an adaptive response to
stressful stimuli prevents insulin resistance as pronounced regulator activity is avoided.
The regulator activity presents the neuroendocrine response to the stressor. Minimal
regulator activity results in minimal to no secretion of GCs.
Selye (1976) also noted the influence of endocrine function on the body’s protective
mechanisms. An overwhelming stressor such as worry was noted to have the ability to
breakdown the body’s protective mechanisms; the resulting breakdown potentially
causing the development of diseases such as T2DM. Sapolsky (2004) addressed multiple
outcomes from excessive cortisol secretion ranging from gastrointestinal complications to
the interruption of sensitive immunological and memory processes.
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Selye’s General Adaptation Syndrome (GAS) and RAM identified the
hypothalamus as the starting point in the endocrine pathway of the stress response (Roy
& Andrews, 1999; Selye, 1976). The hypothalamus is the pivotal point of HPA axis
activation in response to neuroendocrine factors from the limbic system (Dedovic et al.,
2009; Innes et al., 2007). The primary influences from the limbic system include the
amygdala and the hippocampus (Dedovic et al., 2009; Innes et al., 2007). Fear-related
conditioning and behaviors are characteristics of the amygdala, while the hippocampus is
central to learning, memory, and activation of the HPA axis (Innes et al., 2007). Dedovic
et al. (2009) suggested that the amygdala potentiates HPA axis activity while the
hippocampus suppresses activity.
The initial response to a stressor is a developing emotion in the amygdala. With
negative emotions, the hippocampus responds as the individual recalls similar past
experiences in the formulation of a stress response. Considering Lazarus and Folkman’s
(1984) TMS, the variance could represent the impact of life experience, particularly with
negative experiences, as individuals appraise familiar situations as benign.
Fava (1994) concurred with Selye (1976) and Lazarus and Folkman’s (1984)
theories about the influence of life events on the stress response, stating that
neuroendocrine regulation is dependent upon how an individual perceives events. A
benign primary appraisal of a stressor results in little HPA axis activity while appraisals
deeming a stressor as threatening or challenging, and potentially impacting commitments
or beliefs, demand greater HPA axis activity in response to stress.
Chrousos (2000) stated that the secretion of cortisol typically remains within a
stable time-integrated narrow range due to regulatory mechanisms, a negative feedback
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loop. Such regulatory mechanisms include hippocampal response to GCs such as
adrenocorticotrophin hormone (ACTH) and cortisol (Innes et al., 2007; Selye, 1976).
Potential causes of sustained cortisol secretion include depression and visceral obesity.
Hyperactivity of the HPA axis may potentiate the onset of a pseudo-Cushing state
characterized by overt hypercortisolism and insulin resistance (Chrousos, 2000).
Chrousos (2000) concurs with McEwen (1998) as sustained cortisol secretion can result
from an overworked neuroendocrine system with an increasing allostatic load.
Depression, a form of distress, can intensify activity of GCs secondary to
ineffective coping (Chrousos, 2000). The narrow range of circadian cortisol secretion can
be severely influenced by distress (See Figure 4). Individuals with “frequent hits” or a
“prolonged response” from a stressor could develop an allostatic load that increases risk
for developing T2DM.

Figure 4. Circadian Cortisol Secretion and Target Tissue Sensitivity

Figure 4. (A) Circadian cortisol secretion: comparison of non-stressed (NS) individual
(solid black line) with chronic-stressed (CS) individual (dotted line). The CS individual
secretes greater levels of cortisol, particular at lunch as noted by the augmented increase
in cortisol secretion. Dexamethasone (D) test shows exogenous GC had less influence on
the suppression of cortisol secretion in the CS individual. (B) Target Tissue Sensitivity.
The image shows the threshold for harmful effects secondary to cortisol concentration in
individuals who are hypersensitive (HS), normal (N), and resistant (R) (adapted from
Chrousos, 2000, p. S54). Printed with permission for educational purposes.
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Early life stress and a history of chronic emotional stress can impair the regulatory
mechanisms of cortisol secretion (Chrousos, 2000). According to Chrousos (2000),
individuals with chronic distress demonstrate progressive elevations of cortisol
concentrations with age. Feedback regulation of cortisol secretion may become
dysfunctional with aging and, as a consequence, older individuals have elevated resting
levels of cortisol (Sapolsky, 2004). Progressive cortisol elevation that occurs in stressed
individuals may potentiate an equally progressive increase in risk for insulin resistance
and T2DM as individuals age. Blackburn-Munro and Blackburn-Munro (2001) agreed
with Chrousos (2000) and McEwen (1998) by identifying characteristics of chronic stress
and chronic depression that affected HPA axis function. The characteristics included
increased corticotrophin releasing hormone (CRH), altered circadian rhythmicity of
ACTH, increased cortisol, and decreased negative feedback.
Empirical Literature
The risk for T2DM associated with genetics, obesity, and advancing age present
some potential confounding variables that suggest distress could be a mediating variable
in terms of appraisal and coping. During a 30-year study, Li et al. (2012) found that
subjects (n=45,302) exposed to maternal bereavement – death of a father, sibling, or
maternal grandparent – during prenatal life were 31% more likely to develop T2DM than
subjects not exposed to maternal bereavement (aIRR=1.31, CI=1.01-1.69). Individuals
exposed to maternal distress such as bereavement during the prenatal period have an
exaggerated stress response to stressors later in life (Sapolsky, 2004). The literature
suggests that distress may influence the genetic risk that is associated with the
development of T2DM.
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The impact of an exaggerated stress response with cortisol secretion is particularly
alarming when considering the impact on metabolism and the increase of T2DM among
adolescents (Sapolsky, 2004). Obese adolescent males and females are more than twofold more likely to develop T2DM later in life (OR=2.27 [1.41-3.64] and OR=2.08 [1.343.24], respectively) (The, Richardson, & Gordon-Larsen, 2013). Advancing age has also
been associated with the development of diabetes as prevalence rates increased for all age
groups (20-34 years by 1.0%, 35-64 years by 2.7%, and >64 years by 10.0%; p<0.001).
However, obesity explained a greater factor for risk with subjects less than 65 years of
age when compared to subjects over 65 years of age. In the study, data from three time
periods spanning 22 years was evaluated; the prevalence of diabetes among 22,586
subjects increased by 75% (Cheng et al., 2013).
Advancing age appears to influence the relationship between amygdala and
hippocampus activity. Measuring signal change from the amygdala, researchers identified
younger individuals as having heightened emotions in response to both positive and
negative images while older individuals only have heightened emotions in response to
positive images (Carstensen, 2006). Regardless of the risk for T2DM relative to factors
such as genetics, obesity, and advancing age, not all individuals with some or all of these
risks develop T2DM.
The effect of endogenous cortisol on blood glucose control is difficult to interpret
(Netterstrom, Kristensen, Damsgaard, Olsen, & Sjol, 1991). Evaluating the influence that
cortisone, an exogenous steroid, has on blood glucose control provides a means for
understanding the relationship between elevated levels of GCs in the blood and blood
glucose control.

39

Owen and Cahill (1973) examined the influence of cortisone in six obese volunteers
after prolonged starvation. For 35 days, subjects only received one multivitamin, 17
milliequivalents (mEq) of sodium chloride, 13 mEq of potassium chloride, and 1.5 liters
of water. Supplements were sugar free. After the period of starvation (day 35), the
subjects had blood drawn before and 12 hours following a 100 milligram (mg) injection
of cortisone acetate for a period of 6 days. The serum concentrations of glucose and
insulin from day 39 through day 42 were significantly different from the precortisone
period (p<0.05). The limitations of Owen and Cahill’s (1973) study included the small
test group (n=6), narrow spectrum of subjects (obese men), and that one of the subjects
had latent diabetes.
Pagano et al. (1983) caused prednisone-induced insulin resistance in healthy
subjects with ideal body weight and no history of diabetes. Six men and four women
participated. Six subjects were tested six times (three tests with placebo and three with
prednisone) in a random sequence. The four remaining subjects participated in two tests
(one placebo and the other with prednisone).
In addition to the 10 healthy volunteers, 16 surgical patients participated in the
study of prednisone-induced insulin resistance. All of the subjects were of ideal body
weight and had no history of diabetes; all of the surgical subjects planned to receive an
elective cholecystectomy. Six subjects received prednisone while the other 10 subjects
received a placebo (Pagano et al., 1983).
In each instance with placebo or prednisone, the subjects received an infusion of
dextrose and insulin. Prednisone resulted in significantly lower plasma insulin levels and
metabolic glucose clearance (p<0.001); a significant increase in fasting glucose
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production also resulted from the prednisone (p<0.01) (Pagano et al., 1983). Figure 5
provides variances in glucose clearance (glucose transport) as a result of prednisone use.

Figure 5. Glucose Transport Variances Between Placebo ( ) and Prednisone ( )

Figure 5. Prednisone significantly hinders glucose transport as a result of poor
insulin concentrations within cells. p<0.05 and p<0.005 represent the level of
significance for the data in the top section of the figure. 3-OMG stands for 3-orthomethyl-glucose (Pagano et al., 1983, p. 1818). Printed with permission for
educational purposes.
Limitations to the study included the mixed pool of subjects: 10 healthy subjects
divided into two groups according to the number of tests conducted with prednisone and
the placebo, and 16 subjects preparing for elective surgery divided into test (n=6) and
control (n=10) groups. Although the test procedure remained constant, the circumstances
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for the surgical group in terms of distress presented a margin for error. As endogenous
GCs were not accounted for in the surgical group, the study findings presented a potential
for a Type I error.
Despite study limitations, Owen and Cahill (1973) and Pagano et al. (1983)
reasonably demonstrated that exogenous GCs cause insulin resistance. As the stress
response can stimulate the HPA axis, the relationship between endogenous GCs and
insulin resistance was also demonstrated (Owen & Cahill, 1973; Pagano et al, 1983).
Considering the role of allostasis and impact of allostatic load with management of
stressors, research on cognitive processes was evaluated. Dedovic et al. (2009) conducted
a literature review regarding the use of positron emission tomography (PET) and
magnetic resonance imaging (MRI) to examine limbic system activity during stressful
events (Dedovic et al., 2009). The PET results from one study comparing 18 social
phobia subjects with six control subjects showed increased cerebral blood flow from the
amygdala to the hippocampus (Dedovic et al., 2009). In another study, the neural activity
of 40 subjects performing mental arithmetic tasks in a controlled environment was
examined. MRI evaluation of the subjects’ neural activity following the tasks suggested
that hippocampal activity influenced the stress response (Dedovic et al., 2009). Although
the data did not specifically address insulin resistance, activation of the HPA axis by the
hippocampus suggests potential insulin resistance secondary to cortisol secretion.
Shiloah et al. (2003) examined the influence of distress on insulin resistance in 39
subjects with acute psychotic stress. The subjects were graded using a clinical global
impression score (CGI) varying from a score of one to seven with a score of seven
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indicating an extremely mentally ill subject who commonly required forced
hospitalization.
Shiloah et al. (2003) determined that subjects with a CGI score greater than or equal
to six had higher glucose and insulin levels than subjects with a CGI score below six
(p<0.01 and p<0.04 respectively). Scores from the CGI were positively correlated with
glucose and insulin levels (r=0.47, p=0.003 and r=0.37, p=0.021, respectively). The data
indicated that as psychotic stress increased, insulin sensitivity decreased (p<0.02). The
limitations to the study included poor generalizability to populations without psychoses
and the relatively high CGI score needed to demonstrate insulin resistance.
The literature also indicates that depression influences insulin resistance in terms of
cortisol secretion. In a large sample of women across the United States (N=2,662),
depression was associated with an increased risk of 1.66-fold for developing T2DM (95%
CI 1.05-2.61; p < 0.03). This increased risk from depression was more than two-fold for
African American women (95% CI 1.27-5.15; p=0.008) (Everson-Rose et al., 2004).
Subjects with stage II or III breast cancer (N=227) had stress hormones measured over
the course of a year. Overall, having any depressive symptoms was positively associated
with cortisol levels; however, higher depressive symptoms were associated with lower
cortisol levels (p=0.002) (Wu et al., 2014). Wu et al.’s (2014) research findings support
Selye’s (1976) GAS, particularly the stage of exhaustion, and McEwen’s (1998) theory of
allostatic load. Higher depressive symptoms may increase the allostatic load to a point
where neuroendocrine response is insufficient to adapt to the stressor(s).
In a cohort of 1,094 subjects, recurrent episodes of major depression were
associated with obesity (OR=11.63, 95% CI [1.05-128.60]), although the development of
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obesity was not significantly associated with recurrent episodes of major depression
(OR=2.32, 95% CI [0.82-6.58]; Nigatu, Bultmann, & Reijneveld, 2015). Vrany et al.’s
(2015) study on depression and insulin resistance indicated that an increase in BMI
secondary to somatic-vegetative symptoms was a partial mediator between somatic
depressive symptoms and insulin resistance, explaining 23% of the association. Somaticvegetative symptoms can be an individual’s response to secondary appraisal if
management of the stressor – cause for depression – appears to be hopeless or out of the
individual’s locus of control (Lazarus & Folkman, 1984).
An earlier study by Eaton et al. (1996) identified a moderate relationship between
major depressive disorder and the development of diabetes (OR=2.05, p=0.113); adding
obesity slightly increased the risk for T2DM from major depressive disorder (OR=2.23,
95% CI [0.90-5.55]). Although obesity alone has been shown to promote insulin
resistance, obesity doesn’t appear to promote the development of major depressive
disorder.
Kendall-Tackett (2009) suggested that traumatic events and post-traumatic stress
disorder (PTSD) could chronically activate the HPA axis. However, unlike depression,
individuals with PTSD have decreased cortisol and increased sensitivity of the HPA
negative feedback system (Kendall-Tackett, 2000). Morris, Compas, and Garber (2012)
conducted a meta-analysis of 47 studies on the relationship between cortisol and traumaexposed (TE) subjects (N=6,008) with and without resulting PTSD. The researchers
found that although afternoon/evening cortisol levels were lower in TE subjects without
PTSD (d=-0.25, SE=0.09, p=0.007) and TE subjects with PTSD (d=-0.27, SE=0.12,
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p=0.021), subjects with PTSD and major depressive disorder had higher cortisol levels
(d=0.49, SE=0.24, p=0.041).
The decreased cortisol secretion in TE individuals with PTSD may correlate with
the influence of the hippocampus and process of appraisal as described by Lazarus and
Folkman (1984). Traumatic events that promote the development of PTSD may be the
predominant comparative event for individuals during primary appraisal of new stressors.
Although the traumatic event may not seem comparable to other stressors – comparing
sexual assault or active combat to financial turmoil or moving to a new area – the
individual may feel capable of handling new stressors as they are nowhere near as
stressful as the traumatic event. As a result, cortisol secretion of TE individuals with
PTSD may be less than non-TE individuals in similar situations.
The metabolic influence on the development of T2DM secondary to obesity alone
appears to be less influential than when obesity or other known risk factors are combined
with distress such as depression and PTSD. When the researchers control for known risk
factors such as genetic risk and obesity, distress remains a considerable if not significant
factor related to the development of T2DM. Depression can only increase the risk for the
development of T2DM further.
Several studies demonstrated the relationship between insulin resistance and
chronic stress at work (Chandola et al., 2006; Eriksson et al., 2013; Heraclides et al.,
2009; Netterstrom et al., 1991; Vrijkotte et al., 1999). Chronic stress at work increased
the risk for the metabolic syndrome, which increased the risk for T2DM (Chandola et al.,
2006). The metabolic syndrome included abdominal obesity, dyslipidemia, hypertension,
and insulin resistance. Chronic stress at work was defined as having low work social
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support and high job demand greater than 75% of time. Subjects (n=7,034) from a larger
occupational cohort study (N=10,308), the Whitehall II study, met selective criteria and
were followed over 14 years. Workers with chronic stress were found to be at significant
risk for developing metabolic syndrome (p<0.05 for men and p<0.01 for women).
The researchers’ findings suggested that strenuous working conditions promoted
secretion of cortisol and insulin resistance. However, the findings did not demonstrate the
importance of insulin resistance in relation to chronic work stress. Because insulin
resistance is a component of the metabolic syndrome, the importance of chronic work
stress influence on insulin resistance was implied.
Heraclides et al. (2009) demonstrated greater specificity for the connection between
insulin resistance and T2DM when examining a subpopulation of the Whitehall II study.
The researchers examined psychosocial work stress in 5,895 subjects (n=4,166 men and
1,729 women). Psychosocial work stress was identified by job strain and iso-strain. High
work demands and low decisional latitude defined job strain; subjects with the lowest
level of work social support had iso-strain. According to Heraclides et al. (2009), job
strain increased the risk for T2DM by 60%, and iso-strain doubled the risk for T2DM
among women when components of job strain and iso-strain were both present (95% CI).
A total of 308 subjects developed T2DM. The results were not significant. Generalization
of the findings was limited to Caucasians, 35 to 55 years of age, as the researchers
excluded ethnic minorities due to small numbers (n=532). The moderate internal
consistency reliability of the Job Demands Scale used in the original Whitehall II study
presented another potential limitation (α=0.67).
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Netterstrom et al. (1991), Vrijkotte et al. (1999), and Eriksson et al. (2013) also
demonstrated the influence of work stress on insulin sensitivity. The researchers
measured the degree of work stress as a balance between work demands and decisional
latitude or reward for effort.
The Netterstrom et al. (1991) study consisted of 1,504 men and women, aged 30 to
60 years, and examined the influence of work stress on cardiovascular risk factors. High
demands and low decisional latitude on the job accounted for greater stress from work,
identified as job strain (Netterstrom et al., 1991). Subjects with job strain had
significantly higher hemoglobin A1cs (HbA1c) than subjects without job strain (p<0.01).
The researchers suggested that distress from work influenced insulin resistance in
subjects as evidenced by the elevated HbA1c.
The Vrijkotte et al. (1999) study findings demonstrated that insulin resistance
occurred in a high over-commitment group of white collar workers. The degree of overcommitment was determined by the sum of four factors: the need for approval,
competitiveness, the balance between impatience and irritability, and the inability to stop
working due to work expectations. The sample consisted of 124 men, aged 35 to 55
years, working in a large computer company.
Subjects in the high over-commitment group (n=40) showed higher insulin and
glucose levels (p=0.034 and 0.050, respectively) (Vrijkotte et al., 1999). The data
complemented the Netterstrom et al. (1991) findings as the high over-commitment group
also demonstrated insulin resistance. The data from the two studies suggested that work
stress resulting from job demands or ambition produced distress with the risk of
developing insulin resistance and potentially T2DM.
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Eriksson et al. (2013) conducted a study similar to Netterstrom et al. (1991)
following subjects (N=5,432) over a period of 8-10 years. The greatest impact from work
stress occurred in women. Low decisional latitude increased the risk for T2DM more than
two-fold after adjusting for factors such as family history of diabetes and BMI (OR=2.4,
95% CI [1.1-5.2]). The risk for women nearly doubled when low decisional latitude was
combined with high job demands (OR=4.2, 95% CI [2.0-8.7]).
The ability to generalize the data was the primary limitation for the studies. Each
study limited generalization in terms of age because the subjects represented an
unspecified or small proportion of the population, 35 to 55 year old men and or women.
Because Netterstrom et al. (1991) did not specifically identify insulin resistance as a
product of job strain, insulin resistance was assumed in connection with the elevated
HbA1c; assuming an elevated HbA1c as an indication of insulin resistance seemed
permissible with the WHO’s (2011) recognition of HbA1c as diagnostic for T2DM.
Major stressful life events have also been studied related to the onset of T2DM
(Mooy et al., 2000). A random sample consisting of 2,262 non-diabetic Caucasians, aged
50 to 74 years, completed a Serious Life Events Survey followed by an oral glucose
tolerance test. The survey considered events from the previous five years.
Mooy et al. (2000) determined that each event cumulatively increased the risk for
the development of T2DM while controlling for variables such as age and gender (95%
CI, p<0.05). In addition, subjects (n=402) with the highest number of stressful events
(three or more) had a 1.6-fold increased risk for developing T2DM after adjusting for
age, gender, and family history (p<0.05). Five percent (n=112) of the subjects had
previously undetected T2DM.
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Because the sample only included Caucasians, generalization to other ethnicities
could not be made. The data also could not be applied to individuals outside the age
range of 50-74 years.
The amount of distress, appraisal of the stressor(s), and the allostatic load may play
a pivotal role in the development of T2DM over an individual’s lifetime. Novak et al.
(2013) analyzed data from the Multifactor Primary Prevention Trial Study, which
included a random sample of men (N=7,251) that were followed over a period of 35
years. Within the first year, subjective distress evaluations were completed with a single
Likert-scaled question, ranging from one – indicating never having experienced stress –
to six – permanent stress over the previous five years. The risk for T2DM increased by
42% for men with permanent stress after adjusting for age, SES, physical inactivity, BMI,
systolic blood pressure, and use of anti-hypertensive medications (95% CI 1.02-1.96).
Items evaluated in the survey included anxiety or sleeping difficulties secondary to work
conditions.
Preliminary work from a pilot study (N=10) on the topic suggests a relationship
between distress and the development of T2DM. Subjects diagnosed with T2DM within
six months of the study completed the Recent Life Changes Questionnaire (RLCQ) to
determine the amount of distress in terms of stressful life events present near the time of
diagnosis (Miller & Rahe, 1997). Subjects also completed the ENRICHD Social Support
Instrument (ESSI) to determine available social support near the time of the T2DM
diagnosis (Vaglio et al., 2004). A demographic survey was used to determine BMI,
genetic risk for diabetes, age, and HbA1c at the time of the T2DM diagnosis. Analysis of
the data suggested a moderate, positive, non-significant correlation between stressful life
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events and blood glucose control at the time that T2DM was diagnosed (r=0.494,
p=0.147). The limitations included a small convenience sample and rigorous statistical
analyses indicated for a larger sample.
Summary
In examining theoretical concepts, unique elements from the literature were
complementary. The theories presented by Selye, Lazarus and Folkman, and McEwen
provided a detailed view of the stress response when combined. Lazarus and Folkman
(1984) explained the influence of perception and appraisal resulting from environmental
or social factors, and Selye (1976) described the innate process of the stress response and
the effect of cortisol on the body.
Further examination of the emotion and memory complexes of the brain
strengthened the study’s conceptual framework. The amygdala and hippocampus defined
the biological components comprising neuroendocrine regulation secondary to appraisal
of a stressor (Lazarus & Folkman, 1984; McEwen, 2003b). In addition, the opposing
functions of the amygdala and hippocampus in HPA axis activation complemented
Selye’s regard for coping (Dedovic et al., 2009; Innes et al., 2007; Selye, 1976). As Selye
noted, “…it is our ability to cope with the demands made by the events in our lives, not
the quality or intensity of the events, that counts” (1976, p. 177-178).
Early life stress and chronic emotional stress impair regulation of cortisol secretion;
over-activity of the HPA axis promotes insulin resistance (Blackburn-Munro &
Blackburn-Munro, 2001; Chrousos, 2000). Essentially, life events influence
neuroendocrine regulation (Fava, 1994; Kendall-Tackett, 2009). Effective adaptation is
the balance of biological and environmental factors in the process of coping.
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The empirical literature regarding insulin resistance and the onset of T2DM also
presented potentially confounding factors related to established risk factors such as
genetic risk for diabetes and obesity, and described contributing factors to the stress
response and secretion of cortisol. Prenatal exposure to maternal distress and obesity
secondary to recurrent episodes of major depressive disorder suggest that distress
influences established risk factors for T2DM (Li et al., 2012; The et al., 2013).
Owen and Cahill (1973) and Pagano et al. (1983) indirectly supported Selye’s
(1976) GAS with their respective studies on exogenous steroids by demonstrating the
influence of the drugs on insulin resistance. Novak et al. (2013) started a study shortly
after Pagano et al. (1983) published their research to show that endogenous steroids, GCs,
can influence insulin resistance over time in men with considerable distress. Acute
psychoses promoted insulin resistance and increased the risk for T2DM (p<0.05)
(Shiloah et al., 2003). Depression also increases the risk for T2DM secondary to obesity
and or insulin resistance (Eaton et al., 1996; Everson-Rose et al., 2004; Nigatu et al.,
2015; Wu et al., 2014). Individuals who believed that they had high demands and little
support at work or worked excessively to meet expectations also demonstrated insulin
resistance (Chandola et al., 2006; Eriksson et al., 2013; Heraclides et al., 2009;
Netterstrom et al., 1991; Vrijkotte et al., 1999). Unique individual circumstances
influenced adaptability to distress.
The distress from unique circumstances became amplified when traumatic life
events occurred. Mooy et al. (2000) determined that stressful life events significantly
influenced the development of T2DM after adjusting for age, gender, and family history
of diabetes (p<0.05).
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In understanding the nature of the stress response, the psychological influences and
adaptability of the individual must be explored. The theoretical literature outlined the
psychological influences of the stress response from the amygdala and hippocampus, or
the cognator subsystem as described by Roy, and the HPA axis. The empirical literature
provided examples of populations that developed insulin resistance and/or T2DM
secondary to the stress response.
By combining aspects of the theoretical and empirical literature, an area of concern
for further testing of the stress response was developed. An analysis of adaptability in
terms of distress and contextual stimuli or social support in relation to stressful life events
would strengthen current understanding of the stress response as limited research
addresses the topic.
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CHAPTER III
METHODS
The purpose of the study was to examine the influence of stressful life events, social
support, BMI, age at time of T2DM diagnosis, and genetic risk for diabetes on the
development of T2DM. Subjects diagnosed with T2DM within six months of the study
completed the Recent Life Changes Questionnaire (RLCQ) to determine the amount of
distress in terms of stressful life events present near the time of diagnosis (Miller & Rahe,
1997) (See Appendix A); the ENRICHD Social Support Instrument (ESSI) to determine
available social support near the time of the T2DM diagnosis (Vaglio et al., 2004) (See
Appendix B); and a demographic survey to determine BMI, age at time of the T2DM
diagnosis, and genetic risk for diabetes (See Appendix C)
Design
The research was conducted by using a quantitative descriptive design with
correlational and comparative aspects. The pilot study was evaluated to estimate the
effect size, although the results were likely influenced by the small sample size (N=10;
Minks, 2013). The effect size for this study was estimated from data analysis of the pilot
study; specifically, subjects with considerable if not significant RLCQ scores (n=5) and
the standardized coefficient for psychological stress, or distress (b=0.809, p=0.191). See
Table 1 for concepts and definitions.
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Table 1 Concepts, Variables, and Definitions for the Study
Concept
Variable
Theoretical Definition
Blood Glucose
Control (BGC)

Extent of BGC

Genetic Risk for
Diabetes (GRD)

Extent of GRD

Aging

Extent of aging The incremental change
in time as it relates to an
individual’s lifespan.
Amount of
An individual’s weight
BMI
in proportion to the
individual’s height
(ADA, 2004).
Amount of D
The degree of perceived
environmental demands
requiring adaptation
(Lazarus & Folkman,
1984).

Body Mass
Index (BMI)

Distress (D)

Social Support
(SS)

Amount of SS

The degree of variance
between glucose levels
and insulin
concentrations with
higher variance meaning
less control and possible
development of diabetes.
A family history of
diabetes posing genetic
risk for development of
the disease (ADA, 2004).

The degree of perceived
availability of people,
groups, or organizations
that influences an
individual’s ability to
cope (Vaglio et al.,
2004).
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Operational
Definition
Results of a
hemoglobin A1c
laboratory test

Subject answering yes
in response to the
question: “Do you
have a parent,
grandparent, or
sibling with
diabetes?”
Chronological age in
years at the time of
diagnosis
W = kg/m2

The sum of life
change units (LCU)
from stressful life
events
Measurement tool:
1. Recent Life
Changes
Questionnaire
(RLCQ) for major
causes of distress
(Miller & Rahe,
1997)
SS = CM*Psupport
Measurement tool:
1. ENRICHD Social
Support
Instrument (ESSI)

The conceptual model comprises the interactions among the variables. See Figure 6.
Figure 6. Conceptual Model of the Variables for the Study on Stressful Life Events

Extent of Aging

Extent
of GRD

Amount of BMI

Extent of
Blood
Glucose
Control

Social Support

Amount of Distress
(Stressful Life Events)

Figure 6. The conceptual model shows directionality of the influence of variables as they
interact with other variables. The extent of genetic risk for diabetes (GRD) encloses the
amount of blood glucose control as it influences an individual’s insulin sensitivity.
Theoretically, when the amount of social support is unable to suppress the impact of the
amount of distress on the extent of blood glucose control, an individual’s extent of blood
glucose control expands beyond that individual’s genetic risk for diabetes leading to
diagnosis of the disease.
Setting
The study was conducted in an urban region of Missouri in the greater St. Louis
area at SSM Health and VA Medical Centers. For the purpose of this study, urban was
defined as a metropolitan county having 50,000 or more in a population center within its
boundaries (United States Census Bureau, 2015). For the purpose of this study, the
primary area contributing to the population includes Madison County, IL, St. Charles
County, MO, St. Claire County, IL, St. Louis City, MO, St. Louis County, MO (United
States Census Bureau, 2015).
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The medical centers associated with SSM Health Centers are predominantly in St.
Charles County, St. Louis County, and the city of St. Louis (SSM Health, 2016). The
locations of the VA Medical Centers are St. Louis County for Jefferson Barracks and the
city of St. Louis for John Cochran.
Population and Sample
The estimated sample size needed for this study was determined to be 80 subjects as
a result of using G-power analysis with a small effect size (f2=0.10, p<0.05, and 5
predictors). The target population for this study consisted of 40 non-veterans from SSM
Health Centers and 40 veterans from VA Medical Centers, all adults 18 years of age or
older diagnosed with T2DM. The accessible population were patients, 18 years or older
and diagnosed with T2DM, seen at DePaul, St. Clare, St. Joseph, and St. Mary’s Health
Centers (SSM Health Centers) and the John Cochran and Jefferson Barracks (VA
Medical Centers) located in the greater St. Louis, Missouri area.
Inclusion criteria were: 18 years of age or older, a diagnosis of T2DM within the
previous six months of the study, receiving outpatient diabetes care services from one of
the selected medical centers, and willingness to participate in the research. The sample
did not include children, pregnant women, residents of prisons or mental institutions, nor
the mentally handicapped.
Providers were given copies of a cover letter regarding the study (See Appendix D)
to provide to patients if they expressed interest in participation during the time of the
clinical appointment. The cover letter introduced potential subjects to the investigator and
the purpose of the study, and to help potential subjects make an informed decision about
participating in the study. Subjects at the VA received the cover letter in the mail per VA
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IRB approval. Subjects at SSM clinics or hospitals were given a copy of the cover letter
and or had opportunity to read the contents of the cover letter at the time informed
consent was given.
Data regarding the research variables, including age, body mass index (BMI),
genetic risk for DM, and hemoglobin A1c (HbA1c) value at the time of T2DM diagnosis
were obtained from each subject, or the subject’s health care record if the subject was not
certain of specifics related to the questions such as “What was your hemoglobin A1c
level at the time of diagnosis?” The HbA1c value represents the extent of blood glucose
control, relative to insulin concentrations, for the previous 90-120 days during a period of
time that stressful life events may have been experienced. The ethnicity, gender, coexisting mental health diagnoses such as depression or PTSD, level of education, and
marital status were acquired from all subjects at the time of the data collection interview
to further describe the sample. Completed surveys including demographic information,
the Recent Life Changes Questionnaire (RLCQ), and the ENRICHD Social Support
Instrument (ESSI) were stored in a safe in the investigator’s home office until processed.
Only the primary investigator (PI) has access to the key for subjects recruited from SSM
Health Centers. As the VA requires an employee operate as the PI for the study, the PI at
the VA was also aware of the identities of subjects recruited from the VA. During data
analysis, the investigators will compare and analyze the findings of the raw data at a VA
facility, absent of any personal identifiable information for any of the subjects. The raw
data from SSM Health Centers will be destroyed one year following the conclusion of the
study with a paper shredder while the raw data from VA Medical Centers will be
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managed per VA policies and procedures, which requires storage of all data acquired for
seven years.
Protection of human subjects was built into the design. Permission to conduct the
study and provide appropriate protection of human subjects were obtained from the
Committee on Research Involving Human Subjects, College of Nursing, University of
Missouri – St. Louis and the medical centers (See Appendix E). Adults 18 years of age or
older with T2DM receiving outpatient diabetes care services at an SSM Health or VA
Medical Centers were asked to sign a HIPAA release form and a statement of informed
consent (See Appendices F & G) at the time of the interview prior to data collection.
Implied consent for screening were attributed to subjects or healthcare providers
(physicians or diabetes educators) on behalf of the subjects contacting the investigator
about participation in the study.
The only foreseeable potential risk to the subjects that could result from
participation in the study included emotional distress from discussing life changes and
availability of social support. If subjects became emotionally distraught during the
interview, an investigator would listen and provide condolences but not attempt to
counsel. Subjects at SSM Health Centers would be directed to call Behavioral Health
Response, or other entity per IRB preference, for assistance from trained counselors.
Subjects at VA Medical Centers were able to contact a psychologist on site per
behavioral research protocol.
The potential benefits to subjects include clarifying the influence of known risks for
the development of T2DM. Because T2DM is a disease of multifactorial origin,
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determining the potential risk that distress presents in the development of T2DM may
influence the provider’s approach to preventing and treating T2DM.
One subject from the VA subgroup dropped out of the study. The subject was
concerned about the VA using her data for research despite review of informed consent
with relative benefits and risks.
Measurement
Distress, social support, age, body mass index (BMI), blood glucose control, and
genetic risk for DM were examined in the study. The RLCQ measured distress that the
subject experienced due to unique life changes (See Appendix A). The ESSI measured
social support available to the subject (See Appendix B). The demographic survey
provided data to measure age, BMI, blood glucose control, and genetic risk for DM, as
well as descriptive details such as gender and level of education (See Appendix C).
The Recent Life Changes Questionnaire (RLCQ).
The RLCQ was developed to measure the potential influence of distress on the
manifestation of diseases in terms of life change events (Miller & Rahe, 1997). In order
to maintain control between subjects interviewed face-to-face, the investigator read the
items on the RLCQ to all subjects and allowed time for subjects to answer each item. The
investigator completed the survey questionnaire for each subject as appropriate per their
response to each question.
The RLCQ consists of 73 life change events that follow a proportionate scaling
model (Miller & Rahe, 1997). The subjects scored each applicable event in proportion to
a model event. According to Miller and Rahe (1997), subjects usually only acknowledge
10 to 20% of life change events as being influential. To ensure sufficient data for
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analysis, the authors recommended asking about 60 to 75 events in order to obtain six to
15 events that apply to the subject.
Lazarus and Folkman (1984) identified the original instrument – The Holmes-Rahe
Schedule of Recent Experience – as one of the best, if not the best, known instrument of
its time (p.111). However, the original instrument used a complicated proportional
scaling method that required calculating arithmetic and geometric mean data (Miller &
Rahe, 1997). A simplified scaling method was developed and demonstrated high
correlation with the original proportional scaling method (rho=0.92, p<0.001). Subjects
provided numeric evaluation for each relevant event on a scale from 0-100 (Rahe,
Ryman, & Ward, 1980). Relevant events may have the same scores as proportional
scaling and do not require rank-order scoring for events.
The most recent edition of the RLCQ has further simplified the scoring system.
Mean scores were calculated for each event. The PI used the recent edition to simplify the
survey process for participants.
According to Miller and Rahe (1997), many studies have been conducted and
findings have indicated that the 73-item RLCQ demonstrated significant correlation to
perceived stress from life changes when the various samples were compared according to
demographic characteristics: age, gender, marital status, and level of education (r=0.84 to
0.96) (Miller & Rahe, 1997). According to Burns and Grove’s description of construct
validity (2009), the findings from the studies suggested strong construct validity as the
content effectively identified life events for varying samples and predicted compromised
health outcomes from elevated stress.
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The RLCQ’s reliability has varied depending on the sample. Pearson and Long
(1985) found the RLCQ to be reliable when used to evaluate life change in active military
reserves, 18 to 60 years old (n=109, α=0.83). Lee, Chan, and Berven (2007) found the
RLCQ’s reliability to vary from unreliable to reliable in evaluating stress in depressed
subjects with chronic musculoskeletal pain (α=0.47 to 0.75). Rahe (personal
communication, April 15, 2012) reported that an unpublished test-retest run conducted
four weeks apart showed acceptable reliability coefficients for the two subscales (α=0.71
to 0.85). The data collected from multiple studies, despite Lee et al.’s (2007) findings,
indicated that the RLCQ could effectively measure an individual’s perceived distress
from life changes (Pearson & Long, 1985; Miller & Rahe, 1997). The reliability
coefficient for the pilot study (α=0.796) was comparable to Rahe’s reliability coefficients.
According to Miller and Rahe (1997), a total score greater than or equal to 300 life
change units (LCU) for a six-month period or greater than or equal to 500 LCU for a oneyear period is an indication of high life stress. The scores differed to account for the
increased number of events occurring after six months that would influence the level of
significance. Total scores greater than 300 LCU or 500 LCU indicated significant
distress.
The RLCQ takes 5-10 minutes to complete and generates ratio level data (Proqolid,
2011). The events were addressed as simple questions to account for a subject’s
potentially low educational level.
The ENRICHD Social Support Instrument (ESSI).
The ESSI is a seven-question survey that assesses social support (See Appendix B)
(Vaglio et al., 2004). The first question follows a Likert format with a score ranging from
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1-5. A score of one indicates that the subject never had anyone available to talk to while a
score of five indicates that the subject always had someone to talk to. The remaining six
questions are asked in a yes/no format with dichotomous scoring, one for no and two for
yes.
The ESSI has been used to evaluate social support in multiple studies since its
creation (Berkman et al., 2003). Although it was initially designed to study patients that
experienced a heart attack, it is as applicable for patients with chronic diseases (Gottlieb
& Bergen, 2010). In one study of 271 subjects undergoing heart surgery, subjects
completed the ESSI monthly for a period of six months following the procedure (Vaglio
et al., 2004). According to Vaglio et al. (2004), the ESSI demonstrated significant
internal consistency reliability and inter-item associations (r=0.94, α=0.88, p<0.001) and
modest but statistically significant correlations when compared to other social support
instruments (p<0.05).
The ESSI takes approximately 2-3 minutes to complete and generates ordinal level
data (Vaglio et al., 2004). A total score could vary from 7-17 with a higher score
indicating strong social support.
Demographic survey.
The investigator-developed demographic survey included items to measure the
variables of age, gender, ethnicity, marital status, BMI, HbA1c, highest level of
education, genetic risk for DM, and potential pre-existing diagnosis of a mental health
disorder such as depression, anxiety, or PTSD (See Appendix C). Body mass index and
HbA1c values at the time of T2DM diagnosis were collected from the subjects’ health
records at the respective health care setting. Each subject’s height and weight at time of
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diagnosis were gathered from the medical record for accuracy. The existence of a mental
health disorder such as depression and the subject’s view of management in the form of a
dichotomous question – “Do you feel like your current treatment is effective” – prior to
the diagnosis of T2DM was also evaluated. Based upon a review of available literature,
the aforementioned variables were relevant to the study about the effect of distress on the
development of T2DM, or to provide a typical description of a sample of adult humans
(ADA, 2004; Hamman, 1992; Miller & Rahe, 1997; Palinkas et al., 2004).
Age and BMI were noted to be potential risk factors for the development of T2DM
(ADA, 2004; Hamman 1992). Ethnicity, gender, marital status, and highest level of
education were addressed to further describe the sample. Asking subjects if they had a
parent, grandparent, or sibling with T1DM or T2DM acknowledged the genetic influence
for the development of the disease.
Genetic risk for DM, ethnicity, gender, pre-existing diagnosis of a mental health
disorder, and marital status provided nominal level data. Highest level of education
provided ordinal level data. Age, BMI, and HbA1C provided interval/ratio level data.
Data Collection Procedure
Subjects were recruited from diabetes clinics and primary health care provider
offices affiliated with SSM Health and VA Medical Centers. Flyers with general
information and contact information (See Appendix H) hung in exams rooms and the
waiting area at participating hospitals of SSM Health Centers. Similar flyers were also
created for nursing staff in unit breakrooms.
Patients diagnosed with T2DM in the previous six months receiving care as an
outpatient, interested in participating in the study, received a cover letter with information
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about the study and methods for contacting the SSM investigator. Implied consent was
evident when subjects contacted the SSM investigator for initial screening. Informed
consent was obtained from subjects by the SSM investigator where subjects received
diabetes care services prior to the interview. Patients diagnosed with T2DM in the
previous six months receiving care as an inpatient were offered participation in the study
by a nurse or provider. If interested, informed consent was obtained from subjects by the
SSM investigator.
The investigator at VA Medical Centers recruited subjects from established
programs such as Move 101 orientation, nutrition classes, and primary care providers.
Class lists were pre-screened by the VA investigator for inclusion criteria and veterans
were contacted by cover letter with informed consent document prior to the date of a
scheduled class or appointment. The investigator followed up the cover letter and
informed consent by phone to schedule a mutually determined time to meet and complete
questionnaires usually pre or post an established VA appointment. The investigator met
with each vet interest prior to a class or appointment to determine interest. Those willing
to participate completed study questionnaires before or after attending the class or
appointment.
At the time of the data collection interview, the investigator asked the questions
according to the format of the RLCQ, ESSI, and demographic survey, respectively. The
investigators ensured that the RLCQ, ESSI, and demographic survey were completed in
entirety at the end of each subject’s interview. Following completion of the instruments,
the subjects were thanked for their participation.
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Data Analysis
Demographic data were analyzed using descriptive statistics. Descriptive statistics
were also used for research questions one and three. Independent samples t-tests were
also analyzed for research question three. Multiple regression was used to analyze
research question two. The computer program used was SPSS 25.
Descriptive statistics were used for the demographic data of the total sample and for
comparison of the SSM and VA subgroups to determine the mean, mode, range, percent,
and standard deviation of each demographic characteristic as appropriate. The
independent samples t-tests were used to determine if there were significant differences
in the mean BMI, HbA1c, and RLCQ scores for the subgroups. Multiple regression was
chosen to determine the individual and combined effects of the variables – age, BMI,
distress, social support, and genetic risk for diabetes – on the development of T2DM,
recognized by HbA1c (≥6.5%). A block-approach to analysis was conducted to determine
if any independent variables potentially mediate the effect of GRD, and the variables age
and BMI were added in the last two blocks as they are established risk factors for T2DM.
An alpha level of 0.05 was used for statistical comparisons.

65

CHAPTER IV
ANALYSIS OF DATA
This chapter includes data about the study as follows: description of the sample,
findings from the data analysis, limitations of the study, and a summary. Data were
collected from a sample of subjects (n=79) diagnosed with type 2 diabetes (T2DM)
within six months before the date of the interview. Demographic data were reported using
descriptive statistics.
Data based on responses to the Recent Life Changes Questionnaire (RLCQ) (See
Appendix A), the ENRICHD Social Support Instrument (ESSI) (See Appendix B), and a
demographic survey (See Appendix C) were analyzed. The following demographic
variables were evaluated in conjunction with total scores from the RLCQ and ESSI: age,
body mass index (BMI), and family history of diabetes (DM). As age, BMI, and family
history of DM were established risk factors for T2DM (ADA, 2004; Guthrie & Guthrie,
2004; Hamman, 1992), the variables were compared to distress from recent life events
and the available social support during the timeframe of the life events to determine the
amount of influence each independent variable posed.
Description of the Sample
The subjects were recruited from SSM Health Centers and the VA Medical Centers.
SSM Health Centers included DePaul Hospital’s inpatient and outpatient services, St.
Joseph’s Hospital’s inpatient services, and St. Joseph’s Hospital West’s inpatient
services. The VA Medical Centers’ outpatient clinics located in the greater St. Louis,
Missouri area, included John Cochran and Jefferson Barracks. Each health center
required unique approaches to subject recruitment.
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Potential subjects from SSM Health Centers were screened for eligibility to
participate and either invited to participate by providers, nurse educators, or nurses or
directed to a flyer about the study hanging in outpatient exam rooms that had a pull-tab
with the primary investigator’s (PI) contact information (See Appendix G). Cover letters
were provided to providers in outpatient clinics (See Appendix H). If interested in
participating, the PI would arrange time to meet with potential subjects, describe the
purpose of the study, and confirm the potential subject’s interest in participating. Once
interest was confirmed, informed and institutional consents were provided before starting
the interview (See Appendices E & F). Subjects were offered a copy of the consent
forms.
Potential subjects from VA Medical Centers were pre-screened by the PI onsite as
the VA IRB required an employee liaison nurse with PhD to be the PI for the study.
Potential subjects that met the inclusion criteria were mailed a cover letter about the study
and copy of the consent forms. Potential subjects met with the onsite PI (n=4) or student
PI (n=36) before or after the potential subject’s next outpatient appointment regarding the
letter that was mailed to them. If interested, the subject met with the PI in a private exam
room where the PI described the purpose of the study and determined the potential
subject’s interest in participating. If interested, informed consent was provided before
starting the interview. One subject later declined participation after completion of the
interview.
The average subject was a 58 years old, non-Hispanic, married, Caucasian male
with a college degree and a mother with a known diagnosis of diabetes. The average
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subject’s hemoglobin A1c (HbA1c) was 8.3% and BMI was 34.1. Twenty-nine subjects
were diagnosed with a mental illness.
Subjects varied according to selected demographic variables. Table 2 describes the
sample by comparing outcomes for men and women within the subsamples.
Table 2
Demographic Description of Sample Comparing SSM and VA Subjects
SSM (n=40)
VA (n=39)
Overall (N=79)
Men
Women
Men
Women
(n=23)
(n=17)
(n=31)
(n=8)
Age in
52.70
62.29
59.87
53.25
years x̅
57.63 (12.11)
(15.28)
(10.90)
(9.16)
(9.65)
(SD)
BMI x̅
(SD)

34.08 (6.63)

32.64
(7.91)

34.02
(6.12)

34.57
(5.92)

36.41
(6.49)

GRD n

61

16

13

24

8

Mental
Illness n

29

3

7

12

7

Education
M

Some College

High
school
Diploma

Some
College

Some
College

Some
College/
College
Degree

Married or
Living
with
Partner n

42

13

6

21

2

Distress x̅
(SD)

297.61 (201.98)

271.43
(192.68)

307.18
(198.64)

281.94
(213.79)

413.25
(181.61)

Social
Support x̅
(SD)

14.97 (2.30)

15.91
(1.38)

14.88
(2.15)

14.42
(2.73)

14.63
(2.45)

HbA1c x̅
(SD)

8.31 (2.10)

9.26
(2.26)

8.48
(1.97)

7.80
(2.05)

7.18
(0.80)

The RLCQ presented unique findings in terms of events that affected or did not
affect subjects. Of the 73 events listed, 7 events did not apply to the sample within six
months prior to their diagnoses: a demotion, pregnancy, birth of a child, adoption, parents
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divorce, a parent remarried, or held in jail. Of the 73 events listed on the RLCQ, 14
events applied to the sample within six months prior to their diagnoses with considerable
frequency (n≥18). Events listed in table 3 with frequency. To avoid inflating RLCQ
scores for subjects that were inpatients at the time of the interview, two events were not
counted at the time of the interview: an illness or injury that kept the subject in bed for
more than a week or sent the subject to the hospital did not count if the only occurrence
occurred at the time of the interview.
Table 3
Recent Life Changes Questionnaire Events with Frequency ≥18 for the Sample (N=79)
Event

Frequency (Percent of Sample)

An illness or injury that you kept in bed
23 (29.1%)
for more than a week or sent you to the
hospital (74 LCU)
An illness or injury that was less serious
26 (32.9%)
than above (44 LCU)
Major change in eating habits (27 LCU)
22 (27.8%)
Major change in sleeping habits (26 LCU)
24 (30.4%)
Major change in usual type and or amount
18 (22.8%)
of recreation (28 LCU)
Major change in living conditions
18 (22.8%)
(42 LCU)
Change in family get-togethers (25 LCU)
18 (22.8%)
Major change in health or behavior of a
19 (24.4%)
family member (55 LCU)
Change in personal habits (26 LCU)
25 (31.6%)
Change in social activities (27 LCU)
18 (22.8%)
Vacation (24 LCU)
26 (32.9%)
Major decision about immediate future
24 (30.4%)
(51 LCU)
Major purchase (37 LCU)
19 (24.4%)
Moderate purchase (20 LCU)
22 (27.8%)
Note. The frequency score of 18 was chosen due to the mode (n=4) and the next highest
frequency score was 14 with only one occurrence. Other frequency scores with
considerable mode values were less than a frequency score of 10.
Scores from the ESSI varied from 8 to 17. The mean ESSI score was 15.0
(SD=2.3). The predominant modes were ESSI scores of 16 and 17 (n=22 and n=22,
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respectively). Fifteen subjects had ESSI scores less than 14. The majority of subjects had
a strong social support system (See Table 4 and Table 5).
Table 4
Determining the Availability of Support Using the ENRICHD Social Support Instrument
(N=79)
Amount of Time
Question
None
Little
Some
Most
All
Is there someone available to
8
2
4
20
45
whom you can count on to
(10.1%)
(2.5%)
(5.1%)
(25.3%) (57.0%)
listen when you need to talk?
Table 5
Describing the Availability of Support Using the ENRICHD Social Support Instrument
(N=79)
‘Yes’ Responses

Description of Support

Someone available to give [the subject]
67 (84.8%)
good advice about a problem
Someone available who shows [the
74 (93.7%)
subject] love and affection
Someone available to help with daily
60 (75.9%)
chores
Anyone available to provide [the subject]
70 (88.6%)
with emotional support (talking over
problem or helping make a difficult
decision
Have as much contact as [the subject]
63 (79.7%)
would like with someone [the subject]
feels close to in whom [the subject] can
trust and confide in
Currently married or living with a partner
45 (57.0%)
Note. ‘Yes’ responses consists of all subjects that responded ‘yes’ to having the specific
type of support available.
Research Question (RQ) #1: In adults with T2DM, how much distress was present
six months prior to the diagnosis of T2DM?
An individual with an RLCQ score greater than or equal to 300 life change units
(LCU) is considered to have significant stress. Scores from the RLCQ varied from 0 to
801 LCU. The mean RLCQ score was 297.6 LCU (SD=202.0). The median RLCQ was
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269.0 LCU. Two subjects had RLCQ scores of 0 LCU. Despite the mean and median
RLCQ scores being less than 300 life change units (LCU), 36 of the 79 subjects had
significant distress, scores greater than 300 LCU, within the six-month period prior to the
diagnosis of T2DM.
Discussion.
The mean RLCQ score was not significant as it was less than 300 LCU. Although it
was not significant, the subjects had a high amount of distress on average.
Per Miller and Rahe’s (1997) initial RLCQ design, 73 life change events were
addressed with each subject when measuring distress with the goal of 10-20%, or 6-15
events, applying to each subject. From the sample, 33 subjects experienced less than six
events within the previous six months. The majority of the sample (n=46) experienced
more than six stressful life events.
If the 33 subjects were considered outliers as less than six events on the RLCQ
applied to them, and the mean and median were recalculated, a more representative mean
and median may be determined. Only considering subjects that experienced six or more
events (n=46) resulted in a mean RLCQ score of 431.74 LCU (SD=152.5) and a median
RLCQ score of 408 LCU. These scores are greater than 300 LCU and considered
significant.
RQ #2: What is the individual and combined effect of distress, social support, age,
BMI, and GRD on the HbA1c level?
Age, BMI, GRD, distress, and social support explained 8.9% of the variation in the
dependent variable, represented by HbA1c (adjusted R2=.089, F=6.910, p=.010). Two
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variables, age and BMI, significantly explained portions of the total variance in the
dependent variable (β=-.241, p=.031 and β=-.293, p=0.10, respectively) (See Table 6).
Further analysis was done to examine collinearity and the adjusted R2 value. The
VIF values for the variables ranged from 1.034 to 1.063. The range of values is much less
than 8 and suggests no collinearity among variables.
The adjusted R2 value was 8.9%, therefore a regression analysis was conducted
using only the established risk factors age, BMI, and GRD. The established risk factors
explained 11.1% of the variation in HbA1c (adjusted R2=.111, F=4.259, p=.008).
Table 6
Hemoglobin A1c: Examining Risk Factors with Regression Models
Unstandardized
Standardized
Coefficients
Coefficients
Model
B
Std. Error
Beta
t
1
Genetic Risk
4.907E-5
.000
.089
.780
Distress
-.001
.001
-.075
-.654

Sig.
.438
.515

2

Genetic Risk
5.353E-5
Distress
-.001
Social Support
.052

.000
.001
.106

.097
-.075
.057

.838
-.653
.494

.405
.516
.623

3

Genetic Risk
4.368E-5
Distress
-.001
Social Support
.022
Age
-.039

.000
.001
.105
.020

.079
-.092
.024
-.224

.695
-.813
.212
-1.962

.490
.419
.833
.054

4

Genetic Risk
5.925E-5
Distress
.000
Social Support
-.011
Age
-.042
BMI
-.093

.000
.001
.102
.019
.035

.108
-.040
-.012
-.241
-.293

.974
-.358
-.104
-2.195
-2.629

.333
.721
.918
.031
.010
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Discussion.
Age and BMI had the most profound effect on the development of T2DM based on
the analysis of the data collection. These findings are consistent with the wealth of
literature on the risk for T2DM posed by advancing age and obesity (ADA, 2004; Patel &
Macerollo, 2010; The, Richardson, & Gordon-Larsen, 2013). The American Diabetes
Association (2004) summarized the impact of advancing age and obesity on insulin
resistance as T2DM may go undiagnosed for many years. Patel and Macerollo (2010)
stated that clinical practice recommendations are encouraged to diagnose or rule out
diabetes if patients present with hypertension or hyperlipidemia. Assuming practice
recommendations are followed by providers treating patients with a new diagnosis of
hypertension or hyperlipidemia; the only potential issue that would delay early diagnosis
of T2DM, or hypertension or hyperlipidemia, would be a patient that does not see a
provider at least once annually. An assessment leading to a diagnosis of T2DM may be
delayed due to a patient’s undervaluation of the benefit of a well-patient exam.
This study is consistent with others regarding the significant impact of obesity on
the development of T2DM. For example, The et al. (2013) found that obesity persisting
since adolescence can increase the risk for developing T2DM more than two-fold. The
mean age of subjects being less than 65 years in this study also supports the greater
impact of obesity versus age on the development of T2DM for the sample. Cheng et al.
(2013) stated that the prevalence of diabetes for subjects >64 years was nearly four-times
more than for subjects between 35-64 years; however, obesity explained greater risk for
subjects <65 years.
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Distress from stressful life events was not significant to the development of T2DM
for the subjects in this study. There are two possible explanations. First, the onset of
T2DM may have occurred more than 6 months prior to the diagnosis. Measurement of
distress for the six months prior to the diagnosis of T2DM may not be relevant if the
patient has delayed assessment by a provider until complications from hyperlipidemia,
hypertension, or T2DM arise. Second, distress is more than stressful life events.
Reviewing the limitations for the study and the conceptual framework, particularly
McEwen’s (1998) theory of allostatic load, an analysis of distress should include an
inventory of daily stressors.
RQ #3: In adults with T2DM, what is the difference in risk factors between veteran
and non-veteran subjects?
SSM subgroup.
The average subject was a 57 year old, married, non-Hispanic, white male, who had
at least a high school diploma, and a mother, father, or sibling with a known diagnosis of
diabetes. The average subject’s HbA1c was 8.9%, BMI was 33.2, stress score was 287.0
LCU, and had no history of mental illness. Removing the outliers for the subgroup, 21
subjects experienced six or more events with a mean RLCQ score of 432.1 LCU
(SD=146.2).
VA subgroup.
The average subject was a 58 year old, married, non-Hispanic, white male, who had
a college degree, and a mother with a known diagnosis of diabetes. The average subject’s
HbA1c was 7.6%, BMI was 34.9, stress score was 308.9 LCU, and had no history of
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mental illness. Removing the outliers for the subgroup, 25 subjects experienced six or
more events with a mean RLCQ score of 431.5 LCU (SD=160.6).
Analyses to understand the differences in mean BMI, GRD, HbA1c, and RLCQ
scores were conducted. An independent samples t-test and Lavene’s test for equality of
variances were run for each variable in SPSS (See Tables 7, 8, 9, & 10). There was a
significant difference in HbA1c (t=2.768, p=.007). The difference in BMI was not
significant (t=-1.158, p=.250; F=1.040, p=.311). The difference in RLCQ scores was not
significant (t=-.487, p=.628; F=.248, p=.620).
Table 7
Independent Samples T-Test: BMI Comparison for SSM and VA Subgroups
Levene’s Test
t-test for Equality of Means
Sig. (2Mean
Std. Error
F
Sig.
t
df
tailed) Difference Difference
SUM Equal variances 1.040 .311 -1.158
77
.250
-1.723
1.488
assumed
Equal variances
-1.161 75.320
.249
-1.723
1.484
not assumed
Table 8
Independent Samples T-Test: GRD Comparison for SSM and VA Subgroups
Levene’s Test
t-test for Equality of Means
Sig. (2Mean
Std. Error
F
Sig.
t
df
tailed) Difference Difference
SUM Equal variances 7.055 .010 -1.279
59
.206 -1410.556 1103.231
assumed
Equal variances
-1.343 31.739
.189 -1410.556 1050.534
not assumed
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Table 9
Independent Samples T-Test: HbA1c Comparison for SSM and VA Subgroups
Levene’s Test
t-test for Equality of Means
Sig. (2Mean
Std. Error
F
Sig.
t
df
tailed) Difference Difference
SUM Equal variances .967 .329 2.768
77
.007
1.256
.454
assumed
Equal variances
2.773 76.012
.007
1.256
.453
not assumed
Table 10
Independent Samples T-Test: RLCQ Score Comparison for SSM and VA Subgroups
Levene’s Test
t-test for Equality of Means
Sig. (2Mean
Std. Error
F
Sig.
t
df
tailed) Difference Difference
SUM Equal variances .248 .620
-.487
77
.628
-22.247
45.676
assumed
Equal variances
-.486 75.950
.628
-22.247
45.730
not assumed
Discussion.
The average subject from each group had relatively similar ages. Subjects from the
SSM subgroup were more likely to have more than one family member with a known
diagnosis of diabetes while the average subject in the VA subgroup had a mother with a
known diagnosis of diabetes.
The variance in BMI and HbA1c appeared to present an inverse relationship to each
other in examining the outcomes for each subgroup. While the HbA1c was higher for the
SSM subgroup, the age, BMI, and RLCQ scores for the SSM subgroup were lower in
comparison to the VA subgroup.
The relationship between distress and BMI could be explained by coping
mechanisms described by Lazarus and Folkman (1984) and McEwen (1998). The
immediate environment for each subject may present a weak or strong support system
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relative to the type of stressor encountered. For example, where a good friend may have
experience with a challenging process such as adoption, that friend may have conflicting
values in terms of how to raise a child. With no one to help, each subject could choose
from a myriad of measures for coping with a challenge that are also influenced by
subconscious agendas. Agendas could include hope or hopelessness and a loci of control;
if the situation is appraised as hopeless or the subject has no control over the situation,
coping mechanisms may be maladaptive (Lazarus & Folkman, 1984).
Maladaptive responses could also be more complex than excess calorie
consumption for some subjects, where chronic distress from stressful life events may
persist well beyond the six month to one year timeframe used by Miller and Rahe (1997).
In such cases, insulin resistance secondary to chronic or chronic-intermittent secretion of
cortisol. McEwen (1998) identifies such cases as a prolonged response or repeated “hits”
of distress influencing an individual’s allostatic load.
Some subjects shared more detail than required for the interview. Where the RLCQ
only requires yes or no answers in regards to whether or not the subject experienced the
event, some subjects elaborated on the event. The subjects indicated that although one or
more events may not have occurred within the previous six months, the event(s) were still
troubling them. Multiple subjects stated such when asked if they lost a family member or
friend within the previous six months. The response about the relative event would be
“no, but I’m still depressed” or “not within the past six months, but it’s still difficult.”
Considering the theories of Lazarus and Folkman (1984) and McEwen (1998),
subjects may have had trouble coping with the loss of a loved friend or family member.
In response they may have chosen maladaptive coping mechanisms that complicated their
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respective allostatic loads and cortisol secretion. Such maladaptive responses to coping
may be learned behaviors from family members. In the case of distress and BMI, family
members may show support but undermine healthy eating in terms of poor food choices
during times of distress (Wang, Phert, & Lemon, 2014).
Several of the subjects who indicated still struggling with the loss of a loved one
also indicated having a mental illness, typically depression, and that their treatment was
effective. Further clarification of the term “treatment” may be needed in future studies as
subjects in this study may have only considered how they were feeling at the time of the
interview, or included maladaptive coping techniques such as malnutrition as a part of
effective treatment for mental illness.
The relationship between depression and the development of T2DM was well
explained in the literature (Palinkas et al., 2004; Everson-Rose et al., 2004; Khambaty et
al., 2018). The subjects that indicated the loss of a loved one was still difficult or that
they were still depressed also indicated that they believed their treatment for mental
illness was effective. This finding supports Khambaty et al.’s (2018) findings from a
nine-year study on depression and the risk for diabetes; regardless of treatment, a third of
the researchers’ sample (n=39) developed diabetes.
The lower HbA1c in the VA subgroup could be evidence of greater coping
mechanisms from distress regardless of the presence of mental illness, or due to the
number of veterans diagnosed with mental illness. Although the average subject had no
diagnosis of mental illness, nearly half the VA subgroup had a diagnosis of mental illness
(n=19), 10 of which had depression and 8 of which had PTSD (not exclusive of comorbid
depression).
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The lower mean HbA1c for the VA subgroup could indirectly support a metaanalysis of 47 studies conducted by Morris et al. (2012) that concluded subjects with
PTSD and PTSD with major depressive disorder (MDD) had lower daily cortisol output
(d=-.36, SE=.15, p=.008 and d=-.65, SE=.25, p=.008, respectively). Nineteen of the
studies reviewed by Morris et al. (2012) included participants with PTSD and PTSD with
MDD secondary to combat/war experience; 21 of the studies, likely not all exclusive of
the 19 studies regarding combat/war experience, included PTSD and PTSD with MDD
secondary to torture or witnessing a trauma.
Morris et al. (2012) suggest that individuals with PTSD may have lower daily
cortisol production as a form of adaptation to allow for an adequate response to future
threats. Indirectly, this lower daily cortisol production in response to stressful life events
may also result in lower HbA1c levels. Although this adaptive response may be helpful
for individuals with PTSD, diagnosed with T2DM or potentially exposed to future
threats, several authors such as Pervanidou (2008) state that reduction of daily cortisol
output could lead to unregulated sympathetic nervous system activity and increasing
norepinephrine levels leading to sustained hyperarousal and increased sensitivity to fear
and threats promoting anxiety (as cited in Morris et al., 2012).
The variance in stress scores between the two groups presents an interesting
finding. Examining stressful life events up to six months prior to the diagnosis of T2DM
required an RLCQ score of ≥300 LCU to be significant (Miller & Rahe, 1997). Although
the variance was not significantly different from the SSM subgroup, the average subject
from the VA subgroup had significant distress prior to their diagnosis of T2DM.
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Summary
For the sample (N=79) the average subject was a 58 years old, non-Hispanic,
married, Caucasian male with a college degree and a mother with a known diagnosis of
diabetes. The average subject’s hemoglobin A1c (HbA1c) was 8.3%, BMI was 34.1, had
no history of mental illness, an ESSI score of 15, and an RLCQ score of 297.6 LCU.
Age, BMI, GRD, distress, and social support explained 8.9% of the variation in
HbA1c (adjusted R2=.089, F=6.910, p=.010). Age and BMI were significant (β=-.241,
p=.031 and β=-.293, p=0.10, respectively).
The comparison of the average subjects from the SSM and VA subgroups presented
slight differences in age, BMI, GRD, and distress in terms of RLCQ scores. While the
mean HbA1c for the subgroups were significantly different, the differences in age, BMI,
and RLCQ scores were not significantly different.
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CHAPTER V
SUMMARY AND CONCLUSIONS
Summary of the Study
Type 2 diabetes mellitus (T2DM) appears to be a disease of multifactorial origin as
multiple factors influence insulin sensitivity. Genetic risk for disease (GRD), age, BMI,
and distress, from a variety of sources, can promote insulin resistance and the
development of T2DM. The purpose of this study was to examine the influence of
stressful life events, social support, BMI, age, and GRD on the development of T2DM.
The research questions guiding this study included:
1. In adults with T2DM, how much distress was present six months prior to the
diagnosis of T2DM?
2. What is the individual and combined effect of distress, social support, age, BMI, and
GRD on the HbA1c level?
3. In adults with T2DM, what is the difference in risk factors between veteran and nonveteran subjects?
The estimated sample size needed for this study was determined to be 80 subjects as
a result of using G-power analysis with an effect size between small and medium
(f2=0.17, p<0.05, and 5 predictors). Subjects (N=79) were recruited from SSM Health
Centers and VA Medical Centers in the greater St. Louis area. Subjects diagnosed with
T2DM within six months of the potential time of recruitment completed the Recent Life
Changes Questionnaire (RLCQ), ENRICHD Social Support Instrument (ESSI), and an
investigator-developed demographic survey following completion of informed consent at
the time of the potential interview.
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The data was analyzed using SPSS 25. Statistical analyses included descriptive,
multiple regression, and independent sample t-test analyses. An alpha level of 0.05 was
used for statistical comparisons.
Results
The average subject was a 58 years old, non-Hispanic, married, Caucasian male
with a college degree and a mother with a known diagnosis of diabetes. The average
subject’s hemoglobin A1c (HbA1c) was 8.3%, BMI was 34.1, and the subject had no
history of mental illness.
The mean RLCQ score was 297.6 LCU (SD=202.0). Despite the mean RLCQ
scores being less than 300 life change units (LCU), 36 of the 79 subjects had significant
distress. Only considering subjects that experienced six or more events (n=46) resulted in
a mean RLCQ score of 431.74 LCU (SD=152.5) and a median RLCQ score of 408 LCU.
Age, BMI, GRD, distress, and social support explained 8.9% on the variance in
HbA1c (adjusted R2=.089, F=6.910, p=.010). Age and BMI significantly explained
portions of the total variance in the dependent variable (β=-.241, p=.031 and β=-.293,
p=0.10, respectively). Distress was not significant in the model (β=-.040, p=.721).
The VA subgroup had an insignificantly greater mean BMI (34.9 vs 33.2, p=.311)
and mean stress score (308.9 LCU vs 287.0 LCU, p=.620) compared to the SSM
subgroup. However, the VA subgroup had a significantly lower HbA1c in comparison to
the SSM subgroup despite having greater mean BMI and stress score (7.6% vs 8.9%,
p=.007).
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Implications
The implications for healthcare include the prevention or management of T2DM
and the management of mental health disparities, particularly among individuals
diagnosed with major depressive disorder (MDD) or post-traumatic stress disorder
(PTSD). While distress in terms of stressful life events was not significant in this study,
the analyses support existing literature in that advancing age and elevated BMI remain
important factors for consideration in the prevention and management of T2DM. The
inverse relationship between the hemoglobin A1c (HbA1c) and the examined risk factors
BMI and distress among the VA subgroup, in comparison to the SSM subgroup,
presented an unexpected finding. The finding may suggest that individuals with mental
health disparities such as MDD and PTSD may be at greater risk for comorbidities
secondary to hypocortisolism such as irregular immune function or conditions related
unsuppressed norepinephrine release.
Comparison with Literature Review
Building on the research of Li et al. (2013), Mooy et al. (2000), and Novak et al.
(2013), this study used the RLCQ as a more comprehensive assessment of distress. It
examined the amount of available social support in relation to RLCQ scores. Subjects
recalled the six-month period preceding their diagnosis of T2DM and indicated if any of
the events applied to that six-month period of time. This study also revealed an
unexpected qualitative component as some subjects elaborated on life experiences
beyond the yes or no questions that were asked.
Where Li et al. (2013) and Mooy et al. (2000) focused more on their respective
subjects’ experiences with or exposure to loss of loved ones, this study also examined

83

other forms of distressing circumstances that may ultimately be a positive experience
such as getting a promotion with its added responsibilities, or a negative experience such
as financial challenges. The RLCQ questions regarding loss of loved ones had LCU
scores consistent with the impact of such losses described by Li et al. (2012) and Mooy et
al. (2000). The LCU scores for such events ranged from “death of a close personal
friend” at 70 LCU to “loss of a spouse” at 119 LCU (Miller & Rahe, 1997). The impact
of cumulative events identified in Mooy et al.’s (2000) study and McEwen’s (1998)
theory of allostasis supported use of the RLCQ for the measurement of distress in this
study. Analysis revealed that many subjects experienced non-loss related events such as
having a major change in living conditions (n=18) or needing to make a major decision
about their immediate future (n=24) that contributed toward their total RLCQ scores.
This study also examined the differences between veteran and non-veteran subjects.
Examining the combined contribution of distress, social support, age, BMI, and GRD
provided a method for comparing the impact of the risk factors between the subgroups.
Considering the process of appraising distress and the various coping responses described
by Lazarus and Folkman (1984), veterans may have learned to respond to distress
differently as a result of their experiences serving in the military. While their exposure to
the events on the RLCQ may be similar to a non-veteran, the resulting impact on glucose
levels, and ultimately their HbA1c, may be different as a result of a unique appraisal
process and physiological response that uses less cortisol.
Recommendations for Future Research
The gaps in the literature included a comprehensive assessment of distress including
daily or weekly stressors and a comprehensive assessment of mental illness with
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respective treatments in relation to distress. Future research needs to include a
comprehensive assessment of distress and mental illness to better understand the
relationship between distress and the developing of T2DM.
While identifying and understanding the potential risk for T2DM from stressful life
events can be helpful for treating patients struggling with a recent history of multiple
calamities, a methodological approach that incorporates a measure of exposure to stress
similar to Novak et al.’s (2013) study may provide a greater understanding of the
relationship between distress and the development of T2DM. Some individuals may still
experience considerable distress from life and work demands not identified as pinnacle or
unique events on the RLCQ. A daily or weekly stress inventory for individuals at risk for
diabetes with an HbA1c between 5.7% and 6.4% per ADA’s (2019) criteria would
provide greater insight into the impact distress has on the development of T2DM.
A next step is to follow individuals newly diagnosed at risk for diabetes for 6-12
months. A daily distress inventory with a numeric scaling system would be maintained by
subjects. The inventory would evaluate the stressor in terms of who was involved,
duration of the stressful period, and what the individual perceived was at stake (Almeida,
Wethington, & Kessler, 2002). The RLCQ needs to be conducted at six months and or 12
months during follow-up appointments. Analyses would be conducted to examine the
combined effect of stressful life events and daily stressors to provide a broader or twofold definition of distress.
Future research should also address the relationship between mental illness,
particularly MDD and PTSD, and distress as they relate to the development of T2DM. As
this study suggested that individuals with mental illness may have lower HbA1c levels
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than individuals without mental illness, examining how mental illness and associated
treatments impact distress and coping could provide greater understanding of how an
individual’s primary appraisal of a stressor influences insulin resistance secondary to the
cortisol secretion that occurs with the appraisal (Chrousos, 2000; Lazarus & Folkman,
1984; Kendall-Tackett, 2009).
Individuals diagnosed as being at risk for T2DM and being treated for a mental
illness would be followed for 6-12 months. A control group with no mental illness would
also be followed. A daily or weekly distress inventory and mental wellbeing assessment
would be analyzed in relation to scheduled BMI, cortisol, and HbA1c assessments. The
mental illness and control groups would be compared in terms of distress, mental health,
BMI, cortisol levels, and HbA1c.
These approaches to future research would aim to understand how distress and
individual responses to distress, coping, can influence the development of T2DM;
especially in consideration of the conceptual framework comprising the theories of the
stress response, stress appraisal and coping, and allostatic load. Recognizing the
complexity of the stress response and the potential harm posed by dysregulation of
cortisol secretion in homeostasis, understanding how individuals manage distress or
perceive their ability to cope with mounting distress could help clinicians provide optimal
resources or support in the prevention of T2DM.
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APPENDIX A
Recent Life Changes Questionnaire
Health

LCU

An illness or injury that kept you in bed for more than a week or
74
sent you to the hospital
An illness or injury that was less serious than above

44

Major dental work

26

Major change in eating habits

27

Major change in sleeping habits

26

Major change in your usual type and/or amount of recreation

28

Work

LCU

Change to a new type of work

51

Change in your work hours or conditions

35

More work responsibilities

29

Fewer work responsibilities

21

A promotion

31

A demotion

42

A transfer

32

Trouble with your boss

29

Trouble with your coworkers

35

Trouble with those you supervise

35
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Work

LCU

Other work troubles

28

Major business readjustment

60

Retirement

52

Laid off

68

Fired

79

Took a course to help your work

18

Home and family

LCU

Move within same city or town

25

Move to different town, city, or state

47

Major change in living conditions

42

Change in family get-togethers

25

Major change in health or behavior of a family member

55

Marriage

50

Pregnancy

67

Miscarriage or abortion

65

Birth of a child

66

Adoption of a child

65

Relative moves in with you

59

Spouse begins or stops work

46

Child leaves home to attend college or for marriage

41
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Home and family

LCU

Child leaves home for other reasons

45

Change in arguments with spouse

50

Problems with relatives or in-laws

38

Parents divorce

59

A parent remarries

50

Separation from spouse due to work

53

Separation from spouse due to marital difficulties

79

Divorce

96

Birth of grandchild

43

Death of spouse

119

Death of child

123

Death of parent

100

Death of a brother or sister

102

Personal and social

LCU

Change in personal habits

26

Beginning or ending school

38

Change of school or college

35

Change in political beliefs

24

Change in religious beliefs

29

Change in social activities

27

96

Personal and social

LCU

Vacation

24

New, close personal relationship

37

Engagement to marry

45

Girlfriend or boy friend problems

39

Sexual difficulties

44

An accident

48

“Falling out” of a close personal relationship

47

Minor violation of the law

20

Being held in jail

75

Major decision about immediate future

51

Major personal achievement

36

Death of a close personal friend

70

Financial

LCU

Major loss of income

60

Major increase in income

38

Investment and/or credit difficulties

56

Loss/damage to personal property

43

Major purchase

37

Moderate purchase

20

Foreclosure on mortgage or loan

58
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APPENDIX B
ENRICHD Social Support Instrument

1. Is there someone available to whom you can count on to listen to you when you
need to talk?
iii.

None of the time

ii.

A little of the time

iii.

Some of the time

i.

Most of the time

ii.

All of the time

2. Is there someone available to you to give you good advice about a problem?
3. Is there someone available to you who shows you love and affection?
4. Is there someone available to help with daily chores?
5. Can you count on anyone to provide you with emotional support (talking over
problems or helping you make a difficult decision)?
6. Do you have as much contact as you would like with someone you feel close to,
someone in whom you can trust and confide in?
7. Are you currently married or living with a partner?
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APPENDIX C
Demographic Survey
Date of diagnosis: _________________
HbA1C level: ____________________
Age at time of diagnosis: ___________
Height and weight or BMI: __________
Any current diagnosis of mental illness? ____
- Depression
- Anxiety
- PTSD
- Other
If yes to previous question, do you feel like your current treatment is effective? YES /
NO
Gender: MALE / FEMALE
Ethnicity: LATINO / NON-LATINO
Race:
- Arab
- Asian/ Pacific Islander
- Hispanic
- Caucasian/ White
- Other: ____________________________

- Black
- Multiracial

What is your marital status?
- Married
- Divorced
-Separated
- Widowed
- Living with partner

- Single

Do you have a family member that was diagnosed with diabetes? YES / NO
If so:
- Mother
- Father
- Grandparent
- Sibling - Aunt - Uncle
What was your highest level of education?
- 10th grade or less
- High school diploma
- GED
- Some college
- College degree
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APPENDIX D
Informed Consent Cover Letter
SSM Health Center
University of Missouri – St. Louis
Informed Consent Cover Letter
Stress and Type 2 Diabetes
Dear Potential Research Study Participant,
Thank you for your interest in this study. My name is Joshua Minks, and I am a
doctoral student in the nursing department at the University of Missouri – St. Louis.
This research study is designed to look at the relationship between distress and type 2
diabetes. Results of this research will be used to compare the effect of distress to known
risk factors such as family history and obesity at the time a person is diagnosed with type
2 diabetes.
If you volunteer to participate in this study, you will be asked to complete two surveys
and some background information during a face-to-face interview. The interview may
take 10-15 minutes, depending on the time taken to answer questions.
The surveys look at stressful life events and social support. For some individuals,
recalling such events may cause emotional discomfort. The research may benefit future
diabetes studies and the prevention and management of diabetes.
No one will be able to see your personal identifiable information except for myself.
No names will be placed on the surveys. There will be no publicly-known way to connect
you with the information collected as only I will have the consent forms and the
information provided will be coded. Your signed consent will be kept in another file from
your information. You may choose to withdraw at any time during the interview. If you
have any questions about your rights as a research participant, please contact the Human
Subjects Research Office at the College of Nursing, University of Missouri – St. Louis
(314-516-5928).
This research project has been reviewed and approved by the Human Subjects
Research Office at the College of Nursing, University of Missouri – St. Louis and the
Human Subjects Committee associated with the diabetes clinic that you attend.
Again, I thank you for your interest in participating in this study. Please keep this
cover letter for your records.
Sincerely,

Joshua Minks, MSN-FNP, RN
Doctoral Student
Department of Nursing
University of Missouri – St. Louis
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APPENDIX E
Human Subjects Approvals
University
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SSM Health Center
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APPENDIX F
Institutional Consent Forms
University
Department of Nursing
One University Boulevard
St. Louis, Missouri 63121-4400
Telephone: 314-516-6066
Fax: 314-516-7093
E-mail: lavinr@umsl.edu

HIPAA AUTHORIZATION FORM
Authorization for the Use and Disclosure of Personal Health Information
Resulting from Participation in a Research Study
Project Title: The Influence of Stressful Life Events on the Development of Type 2

Diabetes
You have agreed to participate in the study mentioned above. This authorization form explains
how your Protected Health Information will be safeguarded. Please read carefully to be sure
you agree to all of the following statements.

Description of the Protected Health Information
My authorization applies to the information described below. Only this information may
be used and/or disclosed in accordance with this authorization:
Date of type 2 diabetes diagnosis, hemoglobin A1c level at time of diagnosis, age,
weight, height, potential family history of diabetes, gender, ethnicity, marital status, level
of education, potential concurring diagnosis of depression/anxiety/PTSD/or other mental
health diagnosis, amount of distress preceding your diagnosis of type 2 diabetes, and
amount of social support preceding your diagnosis of type 2 diabetes
Who may use and/or disclose the information
I authorize the following persons (or class of persons) to make the authorized use and disclosure
of my PHI: Joshua Minks (PhD Student) and diabetes care providers, including nurses and
diabetes educator

Who may receive the information
I authorize the following persons (or class of persons) to receive my personal health
information: Joshua Minks (PhD Student)
Purpose of the use or disclosure of information
My PHI will be used and/or disclosed upon request for the following purposes:
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☐ Auditing ☐ My treatment during the study
☐ Study outcomes including safety and efficacy ☐ Administrative and billing
☐ Submission to government agencies that may monitor the study
☐ Publications and presentation of results that may identify me as a subject
x Other: determine the potential influence or relationship of each factor (i.e. potential family
history) with the development of type 2 diabetes

Expiration date or event
This authorization expires upon:
☐ The following date:
☒ End of research study
☐ No expiration date
☐ Other:

Right to revoke authorization
I understand that I have a right to revoke this authorization at any time. My revocation must be in
writing in a letter sent to the Principal Investigator at College of Nursing, 1 University Blvd., St.
Louis, MO 63121-4400. I am aware that my revocation is not effective to the extent that the
persons I have authorized to use and/or disclose my PHI have already acted in reliance upon this
authorization.

Statement that re-disclosures are no longer protected by the HIPAA Privacy Rule
I understand that my personal health information will only be used as described in this
authorization in relation to the research study. I am also aware that if I choose to share the
information defined in this authorization with anyone not directly related to this research project,
the law would no longer protect this information. In addition, I understand that if my personal
health information is disclosed to someone who is not required to comply with privacy
protections under the law, then such information may be re-disclosed and would no longer be
protected.

Right to refuse to sign authorization and ability to condition treatment, payment,
enrollment or eligibility for benefits for research related treatment
I understand that I have a right not to authorize the use and/or disclosure of my personal health
information. In such a case, I would choose not to sign this authorization document. I understand
I will not be able to participate in a research study if I do not sign.

Suspension of right to access personal health information
I agree that I will not have a right to access my personal health information obtained or created in
the course of the research project until the expiration of this authorization.
If I have any questions or concerns about my privacy rights I should contact, the HIPAA
Compliance Officer at 314-516-5362.
I have read the above statements and have been able to express my concerns, to which the
investigator has responded satisfactorily. I believe I understand the purpose of the study, as
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well as the potential benefits and risks that are involved. I authorize the use of my PHI and
give my permission to participate in the research described above. I certify that I have
received a copy of the authorization.
All signature dates must match.
_____________________________________________
Participant’s Signature
Date

_
Participant’s Printed Name

_____________________________________________
Parent or Guardian’s Signature
Date

Parent or Guardian’s Printed Name

_____________________________________________
Witness’ Signature
Date

Witness’ Printed Name

_____________________________________________
Researcher’s Signature
Date

The Notice of Privacy Practices (a separate document) describes the procedures used by UM-SL to
protect your information. If you have not already received the Notice of Privacy Practices, the
research team will make one available to you.
_______ I have been offered a copy of the UM-SL Notice of Privacy Practices.
Initial
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SSM Health Center
AUTHORIZATION TO USE AND DISCLOSE PROTECTED HEALTH
INFORMATION (PHI) FOR RESEARCH PURPOSES

The Health Insurance Portability & Accountability Act (HIPAA) is a Federal law that
helps to protect the privacy of your health information and to whom this information may
be shared within and outside of DePaul, St. Clare, St. Joseph, or St. Mary’s Health
Centers. This Authorization form is specifically for a research study entitled “The
Influence of Distress on the Development of Type 2 Diabetes” and will tell you what
health information (called Protected Health Information or PHI) will be collected for this
research study, who will see your PHI and in what ways they can use the information. In
order for the Principal Investigator, Joshua Minks, and the research study staff to collect
and use your PHI, you must sign this authorization form. You will receive a copy of this
signed Authorization for your records. If you do not sign this form, you may not join this
study. Your decision to allow the use and disclosure of your PHI is voluntary and will
have no impact on your treatment at DePaul, St. Clare, St. Joseph, or St. Mary’s Health
Centers. By signing this form, you are allowing the researchers for this study to use and
disclose your PHI in the manner described below.
Generally the Principal Investigator and study staff at DePaul, St. Clare, St. Joseph, or St.
Mary’s Health Centers who are working on this research project will know that you are in
a research study and will see and use your PHI. The researchers working on this study
will collect the following PHI about you: date of type 2 diabetes diagnosis, hemoglobin
A1c level at time of diagnosis, age, weight, height, potential family history of diabetes,
gender, ethnicity, marital status, level of education, potential concurring diagnosis of
depression/anxiety/PTSD/or other mental health diagnosis, amount of distress preceding
your diagnosis of type 2 diabetes, and amount of social support preceding your diagnosis
of type 2 diabetes. This PHI will be used to determine the potential influence or
relationship of each factor with the development of type 2 diabetes. Your access to your
PHI may be limited during the study to protect the study results.
Your PHI will not be identifiable by an investigator assisting with research collection at
John Cochran and Jefferson Barracks. Your completed survey will be coded and only the
Principle Investigator at your hospital, Joshua Minks, will have the key that links your
name with your completed survey. DePaul, St. Clare, St. Joseph, or St. Mary’s Health
Centers, including the SSMSTL Research Compliance department, and Government
representatives or Federal agencies will only have access when required by law.
Your permission to use and disclose your PHI does not expire. However, you have the
right to change your mind at any time and revoke your authorization. If you revoke your
authorization, the researchers will continue to use the information that they previously
collected, but they will not collect any additional information. Also, if you revoke your
authorization you may no longer be able to participate in the research study. To revoke
your permission, you must do so in writing by sending a letter to Joshua Minks, 11830
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Westline Industrial Drive, Suite 106, St. Louis, MO 63146; If you have a complaint or
concerns about the privacy of your health information, you may also contact the SSM
Office of Research Compliance at 314-989-2032 or the CRP/Regulatory Coordinator at
636-496-2538.
The researchers and staff agree to protect your health information by using and disclosing
it only as permitted by you in this Authorization and as directed by state and Federal law.
SSMSTL is committed to protecting your confidentiality. Please understand that once
your PHI has been disclosed to anyone outside of SSMSTL, there is a risk that your PHI
may no longer be protected; however other Federal and State laws may provide continued
protection of your information.

________________________________________
Signature of Subject or Legally Authorized Representative
_________________________________________
Print Name of Subject or Legally Authorized Representative
_________________________________________
Description of Legally Authorized Representative’s Authority
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_________
Date

VA Medical Center
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APPENDIX G
Informed Consent Forms
University
Department of Nursing
One University Boulevard
St. Louis, Missouri 63121-4400
Telephone: 314-516-6066
Fax: 314-516-7093
E-mail: lavinr@umsl.edu

Informed Consent Form
Project Title: The Influence of Stressful Life Events on the Development of Type 2
Diabetes
Investigator: Joshua Minks, MSN-FNP, PhD Candidate
Department: Nursing
University of Missouri – St. Louis
Phone Number: 314-403-3600
I understand that the purpose of this research project is to examine the influence of
stressful life events on the development of type 2 diabetes. I have been chosen to
participate in this study because I was diagnosed with type 2 diabetes within the previous
6 months. I understand that as a research subject I will complete the Recent Life Changes
Questionnaire (RLCQ) to determine the amount of distress in terms of stressful life
events that I experienced near the time of diagnosis. I will complete the ENRICHD social
support instrument (ESSI) to determine available social support present during the same
period of time. I will also provide demographic data (background information) that may
not be available in my medical records.
I understand that the interview may take 10-15 minutes depending on my ability to
recall and answer questions asked of me by the investigator.
I understand that my participation is voluntary; I may refuse to participate and/or
discontinue my participation at any time without penalty or prejudice. The health care
services I receive by the provider that manages my diabetes will not be influenced by my
participation in this study, refusal to participate, or withdrawing from the study.
I understand that all information collected in this study will be held confidential. My
name will not appear on any of the research instruments. My identity will not be
revealed while the study is being conducted or when the study is reported. All data will
be reported as grouped data. Only the investigator will have access to the raw data.
I understand that there may be risk for emotional distress as I recall stressful life
events that I have experienced in the last 6 months to 1 year. If I do become emotionally
distressed, the investigator will listen and allow me to express my concerns but will not
attempt to counsel. The investigator will provide a telephone number for community
counseling or social work services should I become emotionally distressed. While I may
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not personally benefit from the study, study findings may assist those who work in the
area of diabetes management to better serve individuals in need of care.
I understand that by agreeing to participate in this study and signing this form, I have
not waived any of my legal rights.
I understand that any questions or concerns I have regarding my participation in the
project will be addressed by the above named investigator. Should I have any questions
about the rights of research subjects, I may contact the Human Subjects Research Office
at the College of Nursing, University of Missouri – St. Louis (314-516-5928).
___________________________
Subject’s Signature

_____________
Date
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SSM Health Center
Project Title: The Influence of Stressful Life Events on the Development of Type 2
Diabetes
Investigator: Joshua Minks, MSN-FNP, PhD Candidate
Department: Nursing
University of Missouri – St. Louis
I understand that the purpose of this research project is to examine the influence of
stressful life events on the development of type 2 diabetes. I have been chosen to
participate in this study because I was diagnosed with type 2 diabetes within the previous
6 months. I understand that as a research subject I will complete the Recent Life Changes
Questionnaire (RLCQ) to determine the amount of distress in terms of stressful life
events that I experienced near the time of diagnosis. I will complete the ENRICHD social
support instrument (ESSI) to determine available social support present during the same
period of time. I will also provide demographic data (background information) that may
not be available in my medical records.
I understand that the interview may take 10-20 minutes depending on my ability to
recall and answer questions asked of me by the investigator.
I understand that my participation is voluntary; I may refuse to participate and/or
discontinue my participation at any time without penalty or prejudice. The health care
services I receive by the provider that manages my diabetes will not be influenced by my
participation in this study, refusal to participate, or withdrawing from the study.
I understand that all information collected in this study will be held confidential. My
name will not appear on any of the research instruments. My identity will not be
revealed while the study is being conducted or when the study is reported. All data will
be reported as grouped data. Only the investigator will have access to the raw data.
I understand that there may be risk for emotional distress as I recall stressful life
events that I have experienced in the last 6 months to 1 year. If I do become emotionally
distressed, the investigator will listen and allow me to express my concerns but will not
attempt to counsel. The investigator will provide a telephone number for community
counseling or social work services should I become emotionally distressed. While I may
not personally benefit from the study, study findings may assist those who work in the
area of diabetes management to better serve individuals in need of care.
I understand that by agreeing to participate in this study and signing this form, I have
not waived any of my legal rights.
I understand that any questions or concerns I have regarding my participation in the
project will be addressed by the above named investigator. Should I have any questions
about the rights of research subjects, I may contact the Human Subjects Research Office
at the College of Nursing, University of Missouri – St. Louis (314-516-5928).
___________________________
Subject’s Signature

_____________
Date
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APPENDIX H
Flyer for Patients

DIABETES RESEARCH STUDY
Were you diagnosed with type 2 diabetes in
the past 6 months?
Are you 18 years or older?
10-20* minutes of your time could make a
considerable contribution to research on type 2
diabetes.
*Duration depends on time needed to answer questions.
Contact me, arrange a meeting, sign a consent,
and complete 3 short surveys.

I appreciate your time and
consideration.
Sincerely,
J. Minks, Doctoral Student
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